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Green and efficient transformation of ester to amide is a challenging but 
highly wanted reaction for sustainable pharmaceutical manufacturing. While 
the current chemical methods suffer from several drawbacks such as the use of 
toxic reagents, poor atom efficiency and generation of large amount of waste, 
enzyme-catalyzed aminolysis of esters offers a green and direct synthesis of 
amides. However, the number of enzymes known for this transformation is 
limited and the reported substrate range is quite narrow.  This thesis aims to 
develop new enzymes with high performance and broad substrate range for the 
syntheses of amides via aminolysis and expand the scope of synthetic 
application of enzymatic aminolysis in green and sustainable pharmaceutical 
manufacturing. 
In this thesis, an intracellular lipase (SpL) from Sphingomonas sp. HXN-200 
was discovered as a highly active and enantioselective enzyme for aminolysis 
of esters by screening of microorganisms. A recombinant Escherichia coli 
expressing SpL [E. coli (SpL)] was engineered as an efficient and also the first 
whole-cell based aminolysis catalyst. SpL showed high catalytic activity in the 
presence of water (up to 4 vol% for free enzyme and 16 vol% for whole-cell), 
being advantageous over other known aminolysis enzymes, such as Candida 
antarctica lipase B (CALB), which require anhydrous condition. SpL accepted 
a broad range of substrates, catalyzing a series of aminolyses between 
aromatic or bulky amines and bulky carboxylesters for which CALB gave no 
or nearly no activities. As a rare aminolysis enzyme, SpL took also carboxylic 
acids for aminolysis. SpL demonstrated also much better enantioselectivities 




low-cost wet cells of E. coli (SpL) were successfully used for aminolysis to 
produce several amides in high concentration (up to 103 mM) and high yield 
within a short reaction time. 
SpL was then purified in high purity and subjected to crystallization. The 
crystal structure of SpL was solved by X-ray, with a resolution of 1.7 Å.  SpL 
is structurally similar to the carboxylesterase Sto-Est of the hormone-sensitive 
lipase like lipase (HSL-like lipase) family from Sulfolobus tokodaii, 
containing a tunnel with two entrances as the active site. The catalytic triad 
(S159, D251 and H281) was found at the bottom of the tunnel. The crystal 
structures of SpL with 3-amino-5-methylisoxazole and with dimethylarsinic 
acid were also obtained, respectively, which indicate the accessing of an ester 
substrate from entrance 1 and an amine substrate from entrance 2, respectively. 
In comparison with other known aminolysis enzymes such as CALB having a 
catalytic pocket with one entrance, the HSL-like lipase SpL can accept both 
bulky ester and bulky amine substrates simultaneously from two different 
entrances, giving rise to a broader substrate range for aminolysis. The 
thermostable HSL-like carboxylesterase Sto-Est was cloned, expressed and 
produced in E. coli. Sto-Est was found to catalyze also the aminolyisis 
between a series of bulky esters and amines, with similar high activities as 
SpL. The discovery of bacterial HSL-like group of esterase for aminolysis of 
esters provides with new source of aminolysis enzymes for green and efficient 
synthesis of amides and significantly expands the application scope of 
enzymatic aminolysis for amide synthesis. 
A SpL mutant was created to accept a bulky secondary amine substrate by 




to broaden the substrate acceptance. 5 key amino acids residues (W94, A190, 
L209, F217 and L253) around 3-amino-5-methylisoxazole in SpL were chosen 
for site-directed mutagenesis. A190G mutant of SpL was found to catalyze the 
aminolysis of methyl 1H-pyrazole-3-carboxylate with 1-boc-piperazine which 
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Chapter 1. Introduction 
This chapter deals with the research background followed by thesis objectives. 
1.1 The importance of amide bond in the pharmaceutical industry 
Amide bonds are present in a huge array of molecules, including the major 
marketed drugs.1 In 2006, amide bond is identified by Astrazeneca, GSK and 
Pfizer as one of the most important functioning groups in the pharmaceutical 
manufacturing.2 As shown in Table 1.1, among the 1039 chemical 
transformations used for the synthesis of 128 drug molecules, N-acylation to 
amide consists of 84 transformations and the use frequency is as high as 8%, 
demonstrating the indispensable role of this functional group in the 
pharmaceutical industry.2 
Table 1.1 Summary of the reaction categories and use frequencies for the 
synthesis of 128 drugs a (Reprinted with permission, copyright © The Royal 
Society of Chemistry, 2006)2 
 
Reaction category Total Percentage of total reactions 
Heteroatom alkylation & 
arylation 
196 19% 
N-Acylation to amide 84 8% 




Deprotection 159 15% 
Protection 61 6% 
Reduction 94 9% 







Resolution 30 3% 
Miscellaneous 26 3% 
Totals 1039  
 
a Data comes from a survey conducted by the three leading pharmaceutical 





The importance of amide bond in the pharmaceutical industry can also be 
easily seen via looking at the structures of the top selling drugs worldwide. 
According to a survey conducted in 2004, among the 53 small molecule drugs 
whose sales in 2003 exceeded 1 billion USD, 9 drugs contain an amide bond 
as their functioning group.3 
For example, as shown in Figure 1.1, Atorvastatin, the top selling drug used 
to lower blood cholesterol and Lisinopril, the widely used drug for treatment 
of hypertension, both contain an amide bond.4, 5 The most widely used β 
lactam antibiotics, such as penicillin and cephalosporins, contain amide bonds 
both in their rings and on their side chains.6 The biological function of these 
amide bonds is obvious since hydrolysis of these amide bonds will cause the 
loss of antibiotic activity.6 Lysergic acid diethylamide (LSD), a widely used 
entheogen recreational drug and an agent in psychedelic therapy, also contains 
an amide bond.7 
 





1.2 Problems involved in the currently used amide bond formation 
strategy 
In classic chemistry, amide bond formation is normally associated with acid 
chloride intermediates or coupling reagent mediated carboxylic acid and 
amine condensation.1, 8, 9 
Acid chloride involves the use of highly corrosive and reactive halogenated 
reagents such as thionyl chloride, phosphorus trichloride or phosphorus 
pentachloride.8 Although this process has several advantages such as the 
byproduct, SO2 and HCl, can be easily removed by scrubbing through a basic 
solution, significantly low compatibility with acid sensitive functioning groups 
still remains to be a major problem.10 The other key drawback is the high 
corrosivity of the acidic gas released requires special reactors and is a potential 
health threat to the operators.11 
 
Figure 1.2 A two-step procedure for synthesis of amide bond via acid chloride 
intermediate 
 
Coupling reagent mediated carboxylic acid and amine condensation is another 
method for synthesis of amide bond.1, 8 Compared with the acid chloride 
intermediate methodology, coupling reagent eliminates the need for 
intermediate separation and can mediate the reaction in one pot.8 From a 
practical point of view, it is much more convenient.8 
N,N’-Dicyclohexylcarbodiimide (DCC) is the earliest developed coupling 
reagent.1 Unfortunately, the carbamide byproduct (DCU) is difficult to be 




coupling reagents with the carbamide byproduct either quite soluble in water 
or in organic solvent such as EDC, DIPCDI and BDDC have been developed 
to facilitate the product purification.13, 14, 15, 16 
 
Figure 1.3 List of some coupling reagents used for amide bond synthesis 
 
Although having several advantages such as simple one-pot reaction and 
moderate to high amide yield, coupling reagent generates great quantities of 
waste as measured by the E factor and thus is significantly unfavorable 
evaluated from a green chemistry perspective of view.10 Moreover, shock 
sensitive and energy intensive additives such as HOBT are normally 
associated with the coupling reactions, which from a safety perspective of 






Figure 1.4 Reaction mechanism for EDC and HOBT mediated carboxylic acid 
and amine condensation (Reprinted with permission, copyright © 
CommonOrganicChemistry.com) 
 
Actually, in 2005, amide bond formation was identified by the ACS green 
chemistry institute pharmaceutical roundtable as the most widely used but 
problematic reaction in the pharmaceutical industry.10 As shown in Table 1.3, 
amide formation avoiding poor atom economy reagents received all the 6 
votes from the 6 pharmaceutical companies participated in this investigation, 
undoubtedly demonstrating the importance but problem of this reaction in the 
pharmaceutical manufacturing.10 
Table 1.2 Summary of N-Acylation methods and their respective use 
frequencies (Reprinted with permission, copyright © The Royal Society of 
Chemistry, 2006)2 
 
Method Number of examples Frequency 
Acid chloride 37 44% 
Coupling reagent 21 25% 
Mixed anhydride 11 13% 
Carbonyl diimidazole 9 11% 
Other 6 7% 








Table 1.3 Reactions pharmaceutical companies use now but would strongly 
prefer better reagents (Reprinted with permission, copyright © The Royal 
Society of Chemistry, 2007)10 
 
Research area 
Number of Roundtable companies 
voting for this research area as a 
priority area 
Amide formation avoiding poor atom 
economy reagents 
6 votes 
OH activation for nucleophilic 
substitution 
5 votes 




without the use of chlorinated 
solvents 
4 votes 
Safer and more environmentally 
friendly Mitsunobu reactions 
3 votes 
Friedel–Crafts reaction on unactivated 
systems 
2 votes 
Nitrations 2 votes 
 
1.3 Serine hydrolase for amide synthesis 
Nature offers serine hydrolase as an efficient solution for the general problems 
associated with the traditional amide synthesis strategy.18 Three groups of 
serine hydrolases, lipase, subtilisin and penicillin acylase are used for amide 
synthesis now.18 Interestingly, with its natural nucleophile water being 
replaced by unnatural nucleophiles such as amine, amide is produced instead 
of carboxylic acid.19 This offers an excellent alternative for green and direct 


























Figure 1.5 Lipase catalyzed unnatural acyl transferring reactions with 
nucleophile other than water as the acyl acceptor 
 
Enzyme mediated amide bond formation has several advantages as compared 
with the traditional chemical approaches.10 First of all, enzyme catalyzed 
reaction is performed at mild conditions such as room temperature, neutral pH 
and normal pressure and thus is quite suitable for a series of heat, pressure, 
acid or base sensitive molecule synthesis.21, 22 Secondly, enzyme mediated 
amide formation possesses high atom economy.10, 23 With only one molecule 
of alcohol as the byproduct, this strategy offers a much greener and more 
sustainable way for amide synthesis in the pharmaceutical industry.10, 23 Not to 
mention the enzyme catalyzed amide formation is totally exempted from 
shock sensitive reagents such as HOBT.10 In this sense, it can be easily scaled 
up to a manufacturing scale, without much need to worry about safety issues. 
Last but not least, enzymes, as inherently chemo-, regio- and enantio-selective 
catalyst, is especially useful when onerous chemical protection and 
deprotection would otherwise be needed or when a chiral center has to be 




1.4 Problems encountered in the enzymatic way for amide bond 
formation 
Currently, there are three groups of serine hydrolases used for amide 
synthesis-lipase, subtilisin and penicillin acylase.18 Since subtilisin requires 
highly active esters such as 2, 2, 2-trifuoroethyl butyrate as acyl donors and 
penicillin acylase needs phenyl acetic acid or its α-substituted derivatives as 
acyl donors, they are exclusively used for the kinetic resolution of chiral 
amines, where bulky amines are reacted with relatively simple esters.25, 26, 27, 28, 
29, 30 In contrast, lipase shows much broader substrate specificity for both 
esters and amines. Lipase also has other advantages such as high stability in 
organic solvent and little or no amidase activity, which makes it as an ideal 
catalyst for amide synthesis in high yield.31, 32 In this sense, lipase may be 















2-hydroxyphenylacetamide 2-aminophenylacetamide  






However, there are still several major challenges associated with lipase-
mediated amide synthesis. First of all, the range of lipases used so far for 
amide synthesis is quite limited to several well-known lipases such as Candida 
antarctica lipase B (CALB).18, 20, 33 Other lipases, mainly from genus Candida 
and Pseudomonas, such as Candida rugosa lipase (CRL) and Pseudomonas 
alcaligenes lipase (PaL) are also used occasionally, but the narrow substrate 
range of these lipases still makes their pharmaceutical application 
impractical.18, 20 Secondly, the activity of the currently used lipases for 
chemically inert amines such as aromatic amines and bulky amines such as 
secondary amines is low, which makes their industrial application impractical 
due to the expansive existence of these amine moieties in the drug 
molecules.34, 35, 36 Thirdly, the currently used lipase preparations for amide 
synthesis are exclusively free or immobilized enzymes, whose preparation 
generally includes costly enzyme purification, lyophilisation and 
immobilization, which also strongly limit their large scale industrial 
application.2 
1.5 Objectives 
This thesis aims at discovering new enzymes for green transformation of ester 
to amide via aminolysis. More specifically, the thesis objectives are: 
 To discover new enzymes with unique substrate specificity for 
acylation of aromatic amines and secondary amines for green and sustainable 
synthesis of amide bond in the pharmaceutical industry. A series of olive oil, 
methyl hexanoate, octane and toluene degrading strains were screened as wet 
whole cells against the aminolysis of methyl hexanoate with n-pentylamine to 




functioning enzymes present in the wild-type strains were then cloned based 
on a prediction using whole genome information and efficiently expressed in 
Escherichia coli. The enzymes’ unique characteristics such as catalytic 
performance and water content correlation and acceptance for carboxylic acid 
were studied. Substrate scope was also investigated for the cloned enzymes 
with a series of carbonic and heterocyclic esters and amines, especially with a 
series of heterocyclic aromatic amines and secondary amines. The 
enantioselectivities of the cloned enzymes were also investigated with a series 
of model aminolysis reactions and the results were compared with those of 
CALB. 
 To obtain insight into the structural and functional relationship of 
enzyme of interest catalyzed aminolysis of esters. The enzyme of interest 
acquired from strain screening and enzyme cloning was purified and subjected 
to a screening for crystallization conditions. After acquiring the high quality 
enzyme crystals sufficient for X-ray diffraction analysis, the structure of the 
enzyme of interest was solved to a high resolution and the enzyme’s substrate 
binding pocket and active site were found by using known similar enzyme 
structures as templates. The enzyme of interest was also cocrystallized with its 
ester and amine substrates to elucidate its detailed catalytic mechanism. 
Finally, the relationship of the enzyme of interest to other enzymes was 
studied and the enzymes with significant structure similarity to the enzyme of 
interest were further tested towards aminolysis activities to see whether the 





 To further engineer new enzymes with improved activity for secondary 
amines by structure based protein engineering. The amino acid residues 
surrounding the amine substrate in the enzyme-amine complex were identified 
and assumed to be crucial for determining the amine specificity of the enzyme. 
Site mutagenesis of these hot spots was then performed with the goal of 
improving activity for acylating 1-boc-piperazine, a secondary amine with 
significant steric hindrance. 
 To synthesize pharmaceutically important amides efficiently and 
sustainably with the engineered whole cell biocatalyst. The enzyme of interest 
was overexpressed in E. coli and the recombinant E. coli wet cells were used 
directly as whole cell biocatalyst for the synthesis of amides in high 
concentration, high yield and short reaction time. 
1.6 Outline 
Chapter 1 presents a brief introduction to the background and objectives for 
discovering new enzymes for amide synthesis via aminolysis of esters. 
Chapter 2 provides literature review on enzymatic amide synthesis, enzyme 
screening, HSL-like lipases, protein crystallization, protein engineering, 
evolution of lipases and whole cell biocatalyst. Chapter 3 reports the 
discovery of a novel HSL-like lipase SpL by strain screening followed by 
enzyme cloning for efficient amide synthesis with unique characteristics and 
substrate scope. Chapter 4 deals with the crystallization of SpL for 
elucidating the possible amidation mechanism. Chapter 5 focuses on the 
protein engineering of SpL for better acceptance for secondary amines. 
Chapter 6 deals with the conclusion and some recommendations for 




Chapter 2. Literature review 
This chapter introduces state of art of the research field. 
2.1 Biocatalysis in the pharmaceutical industry 
Biocatalysis, different from the traditional chemical catalysis, is the use of the 
natural catalyst-enzymes for the synthesis of chemicals.21, 22 Biocatalysis has 
received more and more attention recently by organic chemists as it conforms 
to the concept of sustainable manufacturing.37, 38 In other words, it helps to 
reduce waste, save energy and protect our environment.37, 38 
 
Figure 2.1 Industrial sectors in which the products of biotransformations are 
used (based on 134 processes) (Reprinted with permission, copyright © 
Elsevier Science Ltd, 1999)39 
 
There have been a series of biotransformation processes developed for 
manufacturing pharmaceuticals. As shown in Figure 2.1, more than half of the 
commercialized industrial biotransformation processes are used in the sector 




Biocatalysis possesses special advantages for the synthesis of structurally 
complex drug molecules or its precursors since the exquisite chemo-, regio- 
and enantio-selectivity offers great advantages of circumventing the onerous 
protection and deprotection procedures and thus dramatically simplifying the 
whole synthetic route.40 As shown in Table 2.1, a series of active 
pharmaceutical ingredients (APIs) with chiral centers have been successfully 





Table 2.1 Recently developed biocatalytic processes in the pharmaceutical 
industry (Reprinted with permission, copyright © Macmillan Publishers 
Limited, 2012)41 
 
Product Technology (company, reference) 
 
Directed evolution primarily for 
enantioselectivity. Intermediate for 




Protein engineering for activity at pH 9 
and IPA, conditions where the ketoamine 




An enzyme obtained by directed 
evolution was used for this intermediate 
for an M1-receptor-positive allosteric 
regulator. (Merck, WO/2011/062853) 
 
A recombinantly expressed (codon 
optimized) enzyme was used to 
manufacture this intermediate for an Axl 
inhibitor on the gram scale. (Rigel, 
US/2010/0196511) 
 
Enzymatic kinetic resolution; lipase from 
Thermomyces lanuginosus; produced on 
the kilogram scale. (Novartis42) 
 
An amine oxidase was improved for 
activity under process conditions, 
including substrate and product 
tolerance. The intermediate is used for 






Processes based on 2-deoxy-D-ribose 5-
phosphate aldolase were developed by 
various companies (DSM, Diversa, 
Pfizer) for this and other statin 
intermediates. The enzyme was 
engineered to withstand high 
concentrations of acetaldehyde and for 
product selectivity; industrial scale. 
(DSM, US/2009/0209001) 
 
2.2 Enzyme-catalyzed amide bond formation via aminolysis of esters 
3 groups of serine hydrolases are used for amide synthesis in the present 
pharmaceutical industry.18 Subtilisin and penicillin acylase are mainly used for 
the kinetic resolution of chiral amines, due to a limited substrate scope of the 
acyl donors.18 Lipase is much more frequently used than subtilisin and 
penicillin acylase for amide synthesis due to the relatively broad substrate 
scope, high stability in organic solvent and little or no amidase activity.31, 32 
The research status of the application of these three groups of serine 
hydrolases for amide synthesis will be discussed respectively in the following 
three subsections. 
2.2.1 Lipase 
Although a diverse array of genetically distinct lipases are found in nature, 
their structural basis is quite similar.43, 44 All of them are built on α/β-sheet 
core structure, which is eight β strands connected by a series of α helices.45, 46 
The catalytic machinery of various lipases also resembles each other.47 A 
catalytic triad containing a nucleophilic serine, an acid residue (usually 
aspartic acid) and a histidine constitutes the active site, as shown in Figure 
2.2.48 The reaction starts with the lipase attacking on the ester bond of its 
substrate, during which a tetrahedral acyl enzyme intermediate is formed by 




residue. The resulting excess of the negative charge that develops on the 
carbonyl oxygen atom is stabilized by the oxyanion hole. Subsequently, the 
tetrahedral intermediate collapses to the serinate ester with elimination of one 
molecule of alcohol as the byproduct. At last, the nucleophile (the acyl 
acceptor) attacks the serinate ester intermediate, affording the product and 
releasing the lipase as its original state. In principle, any nucleophile can react 
with the serinate ester intermediate to give the corresponding product.19 In the 
case of aminolysis, amine, instead of water serves as the nucleophile, thus, 
gives amide instead of carboxylic acid as the final product. 
 
 
Figure 2.2 Reaction mechanism of lipase catalyzed acyl transferring reactions 
(the number of the amino acid residue is for Candida antarctica lipase B); --- 
denotes a hydrogen bond. Step (iii) is the microscopic reversal of steps (i) and 
(ii) (Reprinted with permission, copyright © Elsevier Ltd, 2003)18 
 
Although lipases from various sources have similar structure and catalytic 
mechanism basis, their substrate binding pockets differ from each other in size, 
shape and nature. This offers them different catalytic properties such as 





2.2.1.1 Candida antarctica lipase B 
Candida antarctica lipase B (CALB) is the most widely used enzyme for 
amide synthesis till now.18, 20, 33 It shows quite broad substrate scope and high 
stability in various organic solvent and thus the synthesis of a series of amides 
with various structural features has been demonstrated with CALB as the 
catalyst.49 
 
Figure 2.3 Novozyme 435 (immobilized CALB) catalyzed ammonolysis of 
triolein in t-butyl alcohol 
 
First of all, CALB is a highly efficient catalyst for ammonolysis of esters for 
the synthesis of primary amides. As shown in Figure 2.3, the synthesis of 
oleamide is achieved in high yield via a Novozyme 435-mediated 
ammonolysis reaction of triolein in tert-butyl alcohol.50 CALB is also an 
effective enzyme for accepting ammonia derivatives such as hydroxylamine 
and hydrazine as nucleophiles.51, 52, 53 As shown in Figure 2.4, hydroxamic 
acid and acyl hydrazides were acquired in good yield via a CALB catalyzed 
hydroxylaminolysis or hydrazinolysis of ethyl octanoate or octanoic acid.52 In 
this case, octanoic acid can even be used as the acyl donor to afford the 







Figure 2.4 Hydroxylaminolysis or hydrazinolysis of ethyl octanoate or 
octanoic acid catalyzed by Novozyme 435 
 
Interestingly, CALB is even capable of using carbonates as acyl donors, 
yielding carbamates in high yield, as shown in Figure 2.5.54 Pyrrole-amides 
are also synthesized via CALB catalyzed ammonolysis of (5S)-4,5-dihydro-
1H-pyrrole-1,5-dicarboxylic acid and 1-(1,1-dimethylethyl)-5-ethyl ester.55 
Interestingly, in this case, ammonium carbamate is used as the source of 
ammonia instead of using free ammonia directly.55 (Figure 2.6) 
 
Figure 2.5 CALB catalyzed aminolysis and ammonolysis of carbonates for 
the production of carbamates 
 
 
Figure 2.6 Enzymatic ammonolysis using ammonium carbamate as the source 
of ammonia 
 
Secondly, CALB is also an efficient catalyst for chemo- and regio-selective 
ammonolysis and aminolysis.56, 57, 58 For example, up to 90% amide yield can 
be achieved for CALB-catalyzed chemo-selective ammonolysis and 




n-butylamine, with no or only little enamino ester formed, as shown in Figure 
2.7.57 Regio-selective aminolysis of N-blocked glutamic acid diesters with n-
pentylamine (achieving either α or γ monoamide) is also achieved by changing 
the nature of the N-protecting group of the amino diester.58 
 
Figure 2.7 Chemoselective ammonolysis and aminolysis catalyzed by CALB 
 
Last but not least, CALB is also an enantioselective catalyst for aminolysis of 
a series of racemic esters with racemic amines for preparation of optically pure 
amides. 
 
Figure 2.8 Regioselective aminolysis of N-blocked glutamic acid diesters with 
n-pentylamine mediated by CALB (NHP designates a protected amino group) 
 
For enantioselective acylation of racemic amines, a number of racemic alkyl- 
and arylalkyl-amines have been successfully enantioselectively acylated by 
CALB.35, 59, 60, 61, 62 For example, by employing ethyl acetate as the acyl donor, 
CALB catalyzes efficient enantioselective acylation of racemic 1-aryl-2-
propynylamines to give the (R)-acetamides in high ee and moderate to high 




amino butyrate with isopropyl methoxyacetate is also achieved by using 
CALB as the catalyst, with an E value of 200, as shown in Figure 2.10.64 
 
Figure 2.9 Enantioselective acylation of racemic 1-aryl-2-propynylamines 
















Figure 2.10 Enantioselective acylation of ethyl 3-amino butyrate with 
isopropyl methoxyacetate catalyzed by CALB 
 
CALB also serves as an effective biocatalyst for the enantioselective 
aminolysis of a series of racemic esters.65, 66, 67, 68 One representative example 
is the enantioselective aminolysis of ethyl 3-hydroxybutyrate with 
benzylamine mediated by CALB, as shown in Figure 2.11.69, 70 The (R)-N-
benzyl-3-hydroxybutyramides can be acquired with an ee value >99% and 
yield of 45%.69, 70 
 
Figure 2.11 Enantioselective aminolysis of ethyl 3-hydroxybutyrate with 
benzylamine catalyzed by CALB 
 
The maximal yield of 50% which can be achieved in kinetic resolution 
constitutes a major disadvantage of this process. Fortunately, dynamic kinetic 




with an in situ substrate racemization), offering the possibility of producing 
the enantiopure amides in theoretical maximal yield of 100%.71, 72, 73, 74, 75 
CALB shows a good compatibility with a series of metal-organic complex as 
the racemization reagent.76, 77, 78, 79 A representative example for CALB 
catalyzed dynamic kinetic resolution is the synthesis of optically pure 
acetamide by coupling CALB for enantioselective acylation and a palladium 
catalyst for racemization of the amine described by Kim et al, as shown in 
Figure 2.12.77 
 
Figure 2.12 Dynamic kinetic resolution of racemic amines from ketoximes 
 
Chiral amides were also synthesized via CALB-catalyzed desymmetry of the 
prochiral substrates.80 The most deeply studied prochiral substrate is glutarates. 
CALB proves to be a superior catalyst for desymmetrization of prochiral 
glutarates.81, 82, 83, 84, 85 For example, CALB showed a high enantioselectivity 
towards ammonolysis and aminolysis of dimethyl 3-hydroxyglutarate, 
exclusively producing the (S)-monoamide as the only product, as shown in 
Figure 2.13.84, 85 
 






2.2.1.2 Lipases other than CALB  
Except for CALB, some other lipases, mainly from genus Candida and 
Pseudomonas, were also used as aminolyases occasionally. The substrate 
scope of these lipases is generally much narrower as compared with that of 
CALB. However, some specific substrate preference is observed for some of 
these lipases. 
Candida antarctica lipase A (CALA), another isoform of lipase from Candida 
antarctica, for example, shows a much better performance than CALB for the 
acylation of a series of secondary amines although a worse performance is 
observed for primary amines.86, 87 As a consequence, CALA is widely used in 
cases where sterically hindered amines such as secondary amines are applied 
as the nucleophiles. In amide syntheses, CALA is widely used for the 
acylation of α- and β-amino acid esters.86, 88, 89 For example, by applying 2, 2, 
2-trifluoroethyl butyrate as the acyl donor, CALA mediated an efficient 
enantioselective acylation of methyl pipecolinate with an E value of more than 
100, as shown in Figure 2.14.86 
 
Figure 2.14 Enantioselective acylation of methyl pipecolinate by CALA 
 
Candida rugosa lipase (CRL) is used much less frequently than the Candida 
antarctica lipases (CALs) since instability of this lipase is observed in the 
general aminolysis conditions.20 As a consequence, chemical modifications 
have to be applied to engineer crosslinked crystals of CRL (CLEC-CRL) to 
maintain its catalytic activity in the presence of organic solvent.90, 91, 92 One 




racemic ibuprofen into (S)-ibuproxam using hydroxylamine as the acyl 
acceptor and an E value of 40 is observed, as shown in Figure 2.15.93 
 
Figure 2.15 CLEC-CRL mediated synthesis of (S)-ibuproxam 
 
Except for Candida lipases (CLs), lipases from genus Pseudomonas and 
Burkholderia are also used for amide synthesis. For example, Burkholderia 
cepacia lipase (BCL) is proved to be an effective catalyst for aminolysis of α-
hydroxy benzyl carboxylic acid esters with phenethylamine, as shown in 
Figure 2.16.94 Burkholderia plantarii lipase (BpL), another lipase from genus 
Burkholderia, showed a high enantioselectivity on the acylation of α-
methylbenzylamine with ethyl methyoxyacetate, giving an E value of 114, as 
shown in Figure 2.17.95 
 
Figure 2.16 BCL mediated resolution of benzyl α-hydroxycarboxylates with 
phenethylamine (the enantio-enriched amides and the E values are listed) 
 
 
Figure 2.17 Enantioselective acylation of α-methylbenzylamine with ethyl 
methyoxyacetate catalyzed by BpL 
 
Pseudomonas lipase is normally associated with aminolysis of unbulky esters 




hydrazine can be achieved in the presence of Pseudomonas alcaligenes lipase 
(PAL), as shown in Figure 2.18.53 The same reaction can also be catalyzed 
efficiently by another lipase from Pseudomonas, Pseudomonas lipoprotein.53 
One relatively unstudied lipase from Pseudomonas, Pseudomonas stutzeri 
lipase (PSL), has recently attracted much attention since this lipase proves to 
be an excellent catalyst for catalyzing bulky to bulky ester aminolysis.96 It is 
worthwhile to note that PSL showed a much better performance than CALB 
for aminolysis of a series of carboxylic acid methyl esters when secondary 
amines such as piperidine are used as nucleophiles, as shown in Figure 2.19.96 
 
Figure 2.18 Condensation of octanoic acid with hydrazine catalyzed by 
lipases from Pseudomonas 
 
 
Figure 2.19 Aminolysis of methyl 3-phenylpropionate with N-methyl 
benzylamine and piperidine catalyzed by PSL 
 
Except for lipases from Candida and Pseudomonas, some lipases such as 
Thermomyces lanuginosus lipase (TLL) and Rhizomucor miehei lipase (RML) 
are also used occasionally for aminolysis of esters. For example, TLL is used 
for aminolysis of ethyl octanoate with hydroxylamine or hydrazine and RML, 




of oleic acid with N-methylglucamine or taurine, as shown in Figure 2.20 and 
Figure 2.21.97 
 




Figure 2.21 Condensation of oleic acid with N-methylglucamine or taurine by 
RML 
 
Short peptide synthesis with lipase is also a research area that has received 
much attention since compared with the traditional chemical approaches, 
lipase catalyzed short peptide formation is free of tedious protection and 
deprotection procedures.98, 99, 100, 101 Porcine pancreatic lipase (PPL), a lipase 
from eukaryotes, due to its high activity for α-amino acid derivatives, is 
widely used for the synthesis of a series of short peptides, as shown in Table 





Table 2.2 Short peptides which have been successfully synthesized with PPL 
as the catalyst98, 99, 100, 101 
 













































Subtilisin is a non-specific serine endopeptidase initially obtained from 
Bacillus subtilis.102, 103, 104 It was later discovered that most Bacillus species 
produce subtilisin in large amount.105 Similar to lipase, subtilisin is an organic 
solvent tolerant enzyme. The structure of subtilisin also resembles that of 
lipase, possessing a representative α/β hydrolase fold and a Ser-Asp-His 
catalytic triad.102 The only difference with lipase is that the catalytic triad of 
subtilisin is sterically arranged as the mirror image of lipase, conferring 
subtilisin the reversed enantioselectivity.106 
In contrast to the broad substrate scope of lipase, subtilisin generally requires 
highly active esters such as 2, 2, 2-trifluoroethyl butyrate as the acyl donors 
and thus are exclusively used for the kinetic resolution of chiral amines, where 






Figure 2.22 Enantioselective acylation of 2-aminoheptane and α-
methylbenzylamine by subtilisin (the enantiomer preferably acylated is shown 
with the E value) 
 
Subtilisin proves to be an effective catalyst for enantioselective acylation of 
alkyl-, arylalkyl- and functionalized amines.25, 26, 27, 28, 29, 107 Similar as lipase, 
the resolution is normally performed in anhydrous organic solvent. For 
example, by adopting 3-methyl-3-pentanol as the solvent, the enantioselective 
acylation of a number of racemic alkyl- and arylalkyl-amines such as 2-
aminoheptane and α-methylbenzylamine can be achieved, with most of the E 
values>20, as shown in Figure 2.22.25, 26, 27, 28, 29 
 
Figure 2.23 Enantioselective acylation of trans-2-amino-cyclohexanol and 
phenylalanine amide by subtilisin (the enantiomer preferably acylated is 
shown with the E value) 
 
Functionalized amines, which possess functionalized groups other than the 
amino groups, have also been enantioselectively acylated by subtilisin. For 
example, the enantioselective acylation of functionalized amine trans-2-
amino-cyclohexanol could be achieved in aqueous buffer at pH 8.0 by 
utilizing 2, 2, 2-trifluoroethyl butyrate as acyl donor, as shown in Figure 
2.23.107 The phenylalanine amide can be enantioselective acylated with 2, 2, 2-
trifluoroethyl butyrate as the acyl donor and the S-enantiomer is preferred 




2.2.3 Penicillin acylase 
Penicillin acylase is industrially used for the production of 6-
aminopenicillanic acid from penicillin G.108 It was also widely used for 
resolution of racemic amines, where phenylacetic acid or its α-substituted 
derivatives are used as the resolving reagents. 
Penicillin acylase substantially differs from lipase and subtilisin in structure.109 
Instead of having a catalytic triad, an N-terminal serine residue, activated by a 
bridging water molecule, serves as the active site, as shown in Figure 2.24.109 
 
Figure 2.24 Active site of penicillin acylase with acyl subsite and nucleophile 
subsite (Reprinted with permission, copyright © Elsevier Ltd, 2003)18 
 
In contrast to the broad substrate scope of lipase for acyl donors, penicillin 
acylase is quite specific for phenylacetic acid or its derivatives with small 
substitutions such as hydroxyl or amino groups on the α position.30 Thus, 
similar to subtilisin, it is exclusively used for the kinetic resolution of various 
alkyl-, arylalkyl-amines, aminoalcohols and amino acid derivatives. 
The most widely used penicillin acylase is from E.coli. Recently, penicillin 
acylase from Alcaligenes faecalis also received much attention since it is 
much more stable and suffers less from the parasitic hydrolysis in amine 




Due to the particularity of the active site of penicillin acylase, trace amount of 
water is a prerequisite for conferring its catalytic activity.109 This makes 
aminolysis of esters catalyzed by penicillin acylases a much more complex 
reaction than the case where anhydrous organic solvent is used, since 3 
reactions contribute to the outcome of amide formation, as shown in Figure 
2.25.113 
The first reaction is the ester hydrolysis, which competes with the aminolysis 
for the acyl donor, subsequently causing some acyl donor loss. The second 
reaction is the competition of the amine enantiomers for the acyl donors. 
Under ideal conditions, one amine enantiomer is preferentially acylated. The 
last reaction is the amide hydrolysis, which competes with ester hydrolysis and 
aminolysis for the enzyme active site. This is the reaction which will affect the 
enantioselectivity most since the ee of the enantiomerically enriched amides 
will quickly erode with the faster hydrolysis of the enantiomerically 
preferentially formed amides. 
 
Figure 2.25 Reactions involved in penicillin acylase catalyzed 
enantioselective aminolysis reactions in partially hydrated organic solvent 
 
To achieve an efficient enantioselective acylation, an excess of highly 
activated acyl donors must be present to compete with amide for the enzyme’s 




crucial for achieving the balance between retaining the catalytic activity and 
reducing the hydrolysis of the acyl donors.114, 115, 116 
Penicillin acylase is an efficient catalyst for enantioselective acylation of 
various alkyl- and arylalkyl-amines. For example, penicillin acylase from 
Alcaligenes faecalis shows a high enantioselectivity with an E value >350 for 
acylation of a series of 1-arylethylamine and its derivatives with 
phenylacetamide as acyl donor, as shown in Figure 2.26.117, 118 
A number of aminoalcohols have also been enantioselectively acylated with 
penicillin acylase from A.faecalis. For example, the racemic phenylglycinol 
was enantioselectively acylated with phenylacetamide as the acyl donor and 
the E value is >100, as shown in Figure 2.26.118 Interestingly, with just one 
more hydroxyl group, the enantioselectivity for phenylglycinol is reversed to S 
as compared with the acylation of α-methylbenzylamine, for which the 
enzyme shows a high R selectivity.118 
 
Figure 2.26 Enantioselective acylation of arylalkylamine, aminoalcohol and 
amino acid derivatives by penicillin acylase (the enantiomer preferably 
acylated is shown with the E value) 
 
Penicillin acylase also shows a high enantioselectivity for acylation of amino 
acid derivatives. For instance, in presence of penicillin acylase from E.coli, 
DL-2-phenylglycine methyl ester was enantioselectively acylated with methyl 




dichloromethane and the enzyme showed a high enantio preference for the S-
enantiomer, as shown in Figure 2.26.116 
2.3 Screening of enzymes 
Enzyme screening is often the first step of developing a biocatalysis process. 
The screening library inevitably comes from nature. The biosphere, after 
billions of years of evolution, offers various enzymes with different catalytic 
properties, which in general case, fits into the industrial production perfectly.  
However, our target enzymes are normally mixed with a variety of other 
enzymes and the portion is infinitesimal. Thanks to a variety of efficient 
screening strategies, our target enzymes now can be mined with high 
throughput. 
2.3.1 Resources 
As initial trials, a number of commercially available enzyme collections could 
be fast and readily screened for activities towards the target reaction. Table 
2.3 lists the 6 leading enzyme manufacturers in the world. A variety of 
enzyme preparations can be easily acquired from these suppliers. In fortunate 
cases, these commercially available enzymes can be applied directly for 
specific chemical synthetic applications without further handling.  
Table 2.3 List of leading enzyme manufacturers in the world 
 
Company Country 
Novo Nordisk Denmark 
Genencor International USA 
Cultor Finland 
Chr. Hansen Denmark 






Alternatively, a tremendous source of diverse enzymes could be mined from 
living organisms in nature (mainly microorganisms) for green and efficient 
chemical synthesis. 
Screening of cultivatable microorganisms is one the most commonly used 
methodology for developing novel biocatalysts. A specific cultivation setup is 
normally required where the expression of the targeted activity is mandatory 
for cell growth or survival.119 However, this methodology possesses one major 
limitation as most of the microorganisms cannot be cultivated under laboratory 
conditions. This makes majority of the microorganisms and their gene 
products impossible to access. 
 
Figure 2.27 Flow diagram of a typical metagenome project. (A) Sampling 
from habitat; (B) Filtering particles, typically by size; (C) Lysis and DNA 
extraction; (D) Cloning and library construction; (E) Sequencing the clones; (F) 
Sequence assembly into contigs and scaffolds. (Reprinted with permission, 




Thanks to the rapid development of metagenome technologies, we now can 
access the vast number of uncultivable microorganisms and their enzymatic 
constituents easily. By directly isolating genomic DNAs from environments 
and heterogeneously expressing potential genes in easily cultivable hosts like 
E.coli, a series of previously inaccessible enzymes can be efficiently 
discovered, as shown in Figure 2.27. 
2.3.2 Screening strategies 
The basic principle of screening is the observance of the diminishing of the 
substrates or the accumulation of the products. This normally involves the 
analytical technologies like GC or HPLC. The chromatography strategy is 
widely used when a relatively small library has to be screened. In case of a 
huge library, the relatively low throughput of these screening strategies often 
makes them impractical. 
 
Figure 2.28 High throughput determination of amidase activities using 
fluorophoric assay (Reprinted with permission, copyright © American 
Chemical Society, 2003)120 
 
For efficient screening massive number of samples in short time, fast and 
reliable screening assay is vital. There are a number of versatile screening 
assays developed for rapid and efficient discovery of enzyme activities. The 
use of labelled surrogate substrates or chemical indicators, the monitoring of 




to the reaction of interest are some representative methods involved in the 
development of the high-throughput assays, as shown in Figure 2.28, 2.29 and 
2.30.120, 121, 122, 123, 124 For example, the monitoring of NADH/NADPH 
concentration change is widely used for high-throughput detection of redox 
activities.125 4-nitrophenyl or umbelliferyl moieties, on the other hand, are 
generally associated with rapid screening of hydrolytic activities.126, 127 It is 
worthwhile to note that mass spectroscopy is also used occasionally for fast 
and efficient detection of enzyme activities when high-throughput assay like 
colorimetric assay is not easily available.128 
 
Figure 2.29 Time-resolved IR-thermographic imaging of the lipase-catalyzed 
enantioselective acylation of 1-phenylethanol after a) 0 min, b) 0.5 min and c) 
3.5 min. The control experiment without enzyme is given in the bottom row in 
each case. The bar on the far right is the temperature/color key of the 
temperature window used [oC]. (Reprinted with permission, copyright © 






Figure 2.30 Principle of the adrenaline test for enzymes (Reprinted with 
permission, copyright © WILEY-VCH Verlag GmbH, Weinheim, Fed. Rep. 
of Germany, 2002)123 
 
2.4 HSL-like lipases 
Hormone sensitive lipase (HSL) is a crucial enzyme participating in the 
mobilization of triglycerides stored in the adipocytes of mammals during 
nutrient deprivation or enhanced demand for energy.129 Its vital role in lipid 
metabolism makes it an ideal pharmaceutical target for a series of fatty acid 
level abnormality relevant diseases, including obesity, type II diabetes and 
cardiovascular diseases.130, 131 
HSLs are quite conserved among the various mammalian species. However, 
this family of enzymes are only distantly related to other mammalian lipases 
or esterases, suggesting that it may have a specific origin. All of the 
mammalian HSLs consist of 2 functioning domains: the N-terminal domain, 
which interacts with other proteins such as adipocyte lipid-binding protein 





Interestingly, the C-terminal domain of mammalian HSLs shares significant 
sequence similarity with a series of bacterial lipolytic proteins (HSL-like 
lipases). A significant representing feature of this family of bacterial lipases is 
a highly conserved sequence HGGG presenting upstream of the catalytic triad 
and a conserved catalytic serine residue sitting in a conserved nucleophile 
elbow sequence GDSAGG. In the famous lipase and esterase classification 
system proposed by Jean Louis Arpigny and Karl-Erich Jaeger in 1999, HSL-
like lipases are classified as group IV lipases, composed of a number of family 
members, for which the crystal structure has been successfully solved.44  
HSL-like lipases possess a much broader substrate scope compared with other 
lipases or esterases.132, 133 Not only having high activities for hydrolysing 
various kinds of acylglycerols, HSL-like lipases can also hydrolyze cholesteryl 
esters, retinyl esters, fatty acid esters, steroids and other lipid substrates at 
satisfactory speeds. This offers the possibility of utilizing HSL-like lipases as 
potentially useful biocatalysts for green and efficient synthesis of value added 
fine chemicals in the industry. 
Unfortunately, so far, only a few examples of using HSL-like lipases for 
synthetic applications have been demonstrated. Kinetic resolution of chiral 
carboxylic acids or tertiary alcohols is still the focus of study.134 It is 
worthwhile to note that application of HSL-like lipases for amide synthesis 
has never been attempted. 
2.5 Protein crystallization 
Determining the three-dimensional structure of protein is crucial for 
understanding the function of protein at molecular level.135 In enzymology, 3D 




necessary for carrying on further site directed mutagenesis to improve 
catalytic performance.136  
Techniques such as X-ray crystallography, NMR spectroscopy and electron 
microscopy are developed for determining the structures of proteins.137, 138, 139, 
140, 141, 142 Due to the limitation of NMR spectroscopy for determining large 
protein structures and the unsatisfactory resolution of electron microscopy, X-
ray crystallography is still the most widely used methodology for protein 
structure determination.143, 144, 145 
 
Figure 2.31 General procedure for acquiring the crystal structure of a protein 
(Reprinted with permission, copyright © Nature Publishing Group, 2008)146 
 
To carry out X-ray crystallographic studies, acquiring high concentration of 




2.31.146 Thanks to the genetic engineering technologies, proteins now can be 
engineered with various tags and recombinantly overexpressed in a 
heterologous host to acquire them in large amount and high purities in a short 
time.147 Even after pure soluble protein is available, growing high quality 
crystals remains another major bottleneck for protein structure determination 
since it is normally very hard to predict the protein crystal growth 
conditions.146 
 
Figure 2.32 Three methods for preparing crystals, A: hanging drop; B: sitting 
drop; C: microdialysis (Reprinted with permission, copyright © Wikipedia, 
2010) 
 
To solve this problem, a series of high-throughput screening methods have 
been developed for efficient searching of crystallization conditions, such as 
vapor diffusion and microdialysis, as shown in Figure 2.32.148, 149 
After getting the crystallization conditions, an optimization of the crystal 
growth is normally necessary to acquire high quality crystals sufficient for X-
ray crystallography studies.146 An X-ray beam is then let strike the single 
crystal and X-ray diffraction data are collected as the crystal gradually rotates. 
The data are then processed with software to identify the arrangement of each 
atom in the protein. The biochemical properties are predicted by comparing 





Figure 2.33 From protein crystal to its structure by X-ray crystallography 
(Reprinted with permission, copyright © Wikipedia, 2006) 
2.6 Protein engineering 
In real pharmaceutical manufacturing, some specific catalytic properties of 
enzymes are required such as high thermal stability, high organic solvent 
tolerance and broad substrate scope.150, 151, 152, 153 The wild-type enzymes, 
however, are generally thermal and organic solvent sensitive and can only 
accept narrow range of substrates mimicking their natural ones and thus make 
their real pharmaceutical application difficult. 
Fortunately, protein engineering emerges as a solution to the above mentioned 
problems.41, 154 By creating mutations in the polypeptide chain and searching 
for variants with desired properties, structures are expected to change, so do 
the catalytic properties.  
A series of novel features which do not exist in nature could be created by 
protein engineering. Depending on whether the engineering is based on the 




methodologies, rational design and directed evolution, for engineering a 
protein. 
2.6.1 Rational design 
Rational design is the strategy of creating new proteins with certain 
functionalities, based on the predictions of how structure will affect 
behaviors.155, 156, 157, 158, 159 
 
Figure 2.34 Number of searchable protein structures per year since 2000. 
Note: searchable structures vary over time as some become obsolete and are 
removed from the database (Reprinted with permission, copyright © RCSB 
PDB, 2015) 
 
Thanks to the rapid growth in the protein structures available in protein 
structure data bases such as PDB, rational design has become an inexpensive 
and technically easy way for evolving a protein in short time, as shown in 
Figure 2.34.160, 161 Even when a protein’s real structure is unknown, a 
homology model can be built based on other similar proteins.162, 163, 164 This 
structure model, although not accurate, would still be enough to identify the 





Figure 2.35 Overview of site-directed mutagenesis by a simple PCR, 
phosphorylation, ligation, template removal and transformation (Reprinted 
with permission, copyright © New England Biolabs, 2015) 
 
Site-directed mutagenesis is the most commonly used technique in rational 
design, as shown in Figure 2.35.156 Instead of doing mutations randomly on 
the whole polypeptide chain of the protein, only a few defined amino acid 
mutations inside or near the active site will be introduced in this 
methodology.165 However, due to extreme difficulties involved in predicting 
the effects of various mutations, the positive mutation suggested by 
computation may turn out to have a negative effect in the experiment and 
what’s more, a number of good mutations will be missed by using this strategy. 
2.6.2 Directed evolution 
In contrast to rational design, directed evolution does not require structural 
information. Instead of mutagenesis of specific sites, directed evolution 
involves a random mutagenesis (error-prone PCR or insertion or deletion 
mutation), which creates a much bigger mutant library, for which a high-





After acquiring a series of mutants with better performance, DNA shuffling is 
normally performed next to mix or match pieces of successful variants in order 
to produce even better results.167 Interestingly, the process of directed 
evolution mimics the natural evolution, which normally involves the random 
mutagenesis first, followed by a recombination in a sexual reproduction.168 
The major drawback of directed evolution is that it requires high-throughput 
and this is not always feasible for all the proteins. Fortunately, site-saturated 
mutagenesis is developed for combining the concept of both rational design 
and directed evolution.155 In this methodology, only a few key amino acids are 
mutated but changed to all the other amino acids for creating a much smaller 
library but covering all the possibilities.169  
2.7 Evolution of lipases  
Lipases have been extensively evolved for improvement of either its acyl 
moiety specificity or stability.  
For acyl moiety specificity, a series of properties such as chain length 
preference, regio and enantioselectivity have been changed or improved by 
site directed mutagenesis. For example, a single mutant of Rhizopus delemar 
lipase (V209W) increases the preference against tricaprylin relative to triolein 
one time compared with the wild-type enzyme, which simply shows no 
preference for these two substrates.170 Mutants of Rhizopus oryzea lipase 
(L258A or L258S) with a larger acyl binding site favored the sn1 hydrolysis 
for triglycerides.171 On the other hand, mutants with a smaller acyl binding site 
(L258F or L258F/L254F), preferred the sn3 position hydrolysis.171 The 87th 
and 89th position amino acid residues on the lid of Humicola lanuginosa lipase 




Stabilities such as thermostability, stability against protease and oxidative 
stability have also been improved by protein engineering. For example, the 
temperature stability of Penicillium camembertii lipase has been increased by 
12 oC by introducinig a cysteine bridge between residues C22-C268.173 The 
sensitivity of Pseudomonas glumae lipase and Humicola lanuginosa lipase to 
protease was decreased by either adding proline residues next to the scissile 
peptide bond or exchange protease sensitive lipase loops with protease non-
degradable loops.174, 175 Oxidative stability has also been improved by simply 
exchanging methionines present in lipases with other residues to prevent 
oxidation.176, 177, 178 
Unfortunately, despite of a number of investigations on evolving a lipase, no 
studies have ever been made on improving a lipase’s catalytic performance for 
amide bond formation.  
Chemically inert amine moieties such as aromatic amines and amine moieties 
with great steric hindrance like secondary amines are abundant in drug 
molecules but they are generally unacceptable by the wild-type lipases.18, 20 
Engineering a larger nucleophile binding site, in principle, provides a 
possibility of giving a lipase the ability to accommodate these bulky moieties 
and thus improve the corresponding catalytic activities. 
2.8 Whole cells as catalyst 
The use of whole cells as catalyst, instead of using the purified enzymes, for 
production of active pharmaceutical ingredients (APIs), is attracting more and 
more attention nowadays since compared with isolated enzymes, whole cell 
biocatalyst is more much readily available and economical.40, 179, 180, 181 The 




cell biocatalyst due to it enables the overproduction of desired enzymes in a 
series of heterologous hosts and thus dramatically increases the specific 
activity of the catalyst to meet the industrial production requirement.181 
Having other advantages such as increased stability due to the protection of 
functioning enzymes from the external environment by the cell membranes 
and exempt from exogenous co-factor for re-dox reactions, a series of whole 
cell biocatalyst has been commercialized for the efficient production of a 
series of valuable compounds, as shown in Table 2.4.181 
Table 2.4 Examples of utilizing whole cell biocatalysts for producing 
compounds with commercial interest (Reprinted with permission, copyright © 





For example, (S)-2-chloropropionic acid is acquired by a dehalogenation 
resolution of (R, S)-2-chloropropionic acid with a Pseudomonas whole cell 
biocatalyst by Avecia.182 L-pipecolic acid is produced from L-Lysine with a 
recombinant E.coli whole cell biocatalyst overexpressing a lysine 
aminotransferase by Mercian.183 
However, there are still several disadvantages of using the whole cells as 
catalyst as compared with using purified enzymes. Firstly, mass transfer 
resistance caused by cell membrane remains to be a major shortcoming of 
using whole cells directly as catalyst.181 To overcome this disadvantage, a 
series of permebilization methods have been developed to increase the 
accessability of the substrates from the enzymes inside the cells and also to 
help the release of the products.184, 185, 186 Side reactions, which lead to 
degradation of products and accumulation of byproducts, are also a noticeable 
disadvantage involved in whole cell biocatalyst.181 Fortunately, this 
disadvantage can be efficiently overcome by using recombinant strains instead 
of wild-type strains as catalyst.181 
For amide synthesis, the currently used lipase preparations are exclusively free 
















Chapter 3. Discovery, genetic engineering, and 
synthetic application of intracellular lipase SpL for 
efficient amide synthesis via aminolysis of esters with 
broad substrate range 
3.1 Introduction 
Amide bonds are present in most of drug molecules. The current amide 
synthesis method often involve the use of acid chlorides and coupling reagents, 
thus suffering from the use of corrosive reactants and shock sensitive reagents, 
poor atom economy, and the generation of large amount of waste. Amide bond 
formation has been recognized as a key green chemistry reaction that needs 
improvement for pharmaceutical manufacturing.  
Enzymatic aminolysis of esters or carboxylic acids with amine could offer a 
useful, green, and direct synthesis of amides. However, the currently reported 
enzymes (lipases) for aminolysis of ester are limited to several well-known 
lipases and unable to accept bulky amines such as secondary amines and 
aromatic amines;  
Moreover, all known lipases-catalyzed aminolysis of esters for amide 
synthesis, except the use of strong nucleophiles such as hydroxylamine or 
hydrazine,51, 52 require the use of dry catalyst powder in anhydrous solvent, 
which significantly enhances the process cost and energy consumption.   
Finally, all reported lipases are extracellular, being unable to use whole-cells 
catalysts, which are cheap and easily available in large scale, for amide 
synthesis via aminolysis in an economic manner. 




Sphingomonas sp. HXN-200 and the development of recombinant E. coli 
expressing this lipase as active, enantioselective and easily available wet 
whole cell biocatalyst for the practical preparation of a series of 
pharmaceutically useful and valuable amides via aminolysis of esters. 
3.2 Experimental section 
3.2.1 Chemicals 
All the chemicals were obtained from commercial suppliers and used without 
further purification: octane (≥99%, Sigma Aldrich), 4-nitrophenyl butyrate 
(≥98%, Sigma Aldrich), methyl benzoate 1a (99%, Alfa Aesar), methyl 
cyclohexanecarboxylate 1b (≥ 98%, Aldrich), methyl hexanoate 1c (>99.5%, 
TCI), methyl 3-phenylpropionate 1d (>98%, TCI), 3-phenylpropionic acid 4a 
(>98.0%, TCI), (rac)-methyl mandelate 1g (97%, Alfa Aesar), methyl (S)-(+)-
mandelate (S)-1g (≥99%, Aldrich), benzylamine 2a (99%, Aldrich), aniline 2b 
(≥99.5%, Sigma-Aldrich), phenethylamine 2c (≥99%, Aldrich), n-pentylamine 
2d (99%, Aldrich), (R)-(-)-1-cyclohexylethylamine (R)-2j (98%, Sigma 
Aldrich), (S)-(+)-1-cyclohexylethylamine (S)-2j (98%, Sigma Aldrich), α-
methylbenzylamine 2k (99%, Aldrich), (R)-(+)-α-methylbenzylamine (R)-2k 
(98%, Aldrich), 1H-pyrazole-3-carboxylic acid 4b (97%, Sigma Aldrich), 2-
picolinic acid 4c (99%, Sigma Aldrich), methyl picolinate 1f (>98.0%, TCI), 
3-Aminopyrazole 2e (98%, Sigma Aldrich), 5-Amino-1,3-dimethylpyrazole 2f 
(97%, Sigma Aldrich), 3-amino-5-methylisoxazole 2g (≥98%, Sigma Aldrich), 
2-(Aminomethyl)benzimidazole dihydrochloride 2h (98%, Sigma Aldrich), 2-
oxopiperazine 2i (97%, Sigma Aldrich), sodium bicarbonate (99%, Sigma 
Aldrich), sodium sulfate (≥99.0%, Sigma Aldrich), sulfuric acid (≥98%, 




(HPLC grade, TEDIA), ethyl acetate (HPLC grade, Fisher), chloroform 
(HPLC grade, Fisher), methanol (99.8%, Sigma Aldrich), acetonitrile (HPLC 
grade, TEDIA), N,N-dimethylformamide (99.8%, Sigma Aldrich), 
dichloromethane (≥99.8%, Sigma Aldrich), tert-butyl methyl ether (99.8%, 
Sigma Aldrich), tetrahydrofuran (≥99.9%, Sigma Aldrich), isopropanol 
(HPLC grade, Fisher), thionyl chloride (≥99.0%, Fluka), EDCI (≥99.0%, 
Sigma Aldrich), HOBT (≥99.0%, Fluka), triethylamine (≥99%, Sigma 
Aldrich), benzyl alcohol (≥99.0%, Sigma Aldrich), 1-phenylethanol (98%, 
Sigma Aldrich), trifluoroacetic acid (99%, Sigma Aldrich) and molsieve 4A 
(powder, 325 mesh, Sigma Aldrich). 
3.2.2 Strains, plasmids and biochemicals 
The strains, DNAs and plasmids used in this study are listed in Table 3.1.  
Table 3.1 Strains, DNAs and plasmids used in this study 
 
Strains, DNAs or plasmids Characteristics Reference 
T7 express E.coli Expressing strain NEB 
Genomic DNA of 
Sphingomonas sp. HXN-200 
DNA template Our group 
pRSFDuet-1 Expression vector Novagen 
 
Restriction enzymes (NdeI, BglII, BamHI and XhoI) and T4 DNA quick 
ligase were purchased from New England Biolabs. Oligos (primers), IPTG 
(inducer, >99%), agarose (molecular biology grade) and 10×TAE buffer 
(ultrapure grade) were purchased from 1st BASE, Singapore. Monopotassium 
phosphate (≥99.0%), dipotassium phosphate (≥98%), ammonium chloride 
(≥99.5%), magnesium sulfate (≥99.5%), calcium chloride dihydrate (≥99.0%), 
imidazole (≥99%), kanamycin (>99%), glycerol (≥99%) and Bradford reagent 




miniprep kit, gel extraction kit and PCR purification kit were purchased from 
Thermo Scientific. DNeasy blood & tissue kit was acquired from Qiagen. LB 
broth, LB agar, tryptone and yeast extract were purchased from Biomed 
Diagnostics. 4%–12% NuPAGE® Bis-Tris precast gels (in MES-SDS Running 
Buffer) were acquired from life technologies. Novozyme 435 was a gift from 
Novozymes (Bagsvaerd, Denmark). DNA sequencing was carried out by 1st 
BASE, Singapore. 
3.2.3 Strain screening 
Strain screening was performed by first isolating strains using olive oil, methyl 
hexanoate, octane or toluene as the sole carbon source followed by the activity 
screening using aminolysis of methyl hexanoate with n-pentylamine as the 
model reaction. 
 
Figure 3.1 General procedures for isolating lipolytic strains 
3.2.3.1 Olive oil as the sole carbon source  
Olive oil was used as the sole carbon source for enrichment culture to discover 
lipolytic enzymes with long chain preference. Rhodamine B was used as an 
indicator for high-throughput screening of lipase activity. 
Soil samples were collected from various spots in Singapore such as gardens, 
restaurants and chemical plants to increase the possibilities of acquiring 




The detailed procedure for strain isolation is listed as follows: 
1 g of soil sample was added into 100 ml of sterilized DI water in a 250 ml 
shaking flask and the suspension was shaken at 30 oC, 250 rpm for 1 h. 10 ml 
of the supernatant was taken and inoculated into 100 ml M9 medium with 1 g 
of olive oil present as the sole carbon source and the suspension was shaken at 
30 oC, 250 rpm for 2 days. 10 ml of the 1st round enrichment culture broth was 
taken and inoculated into another 100 ml fresh M9 medium with 1 g of olive 
oil present and the suspension was shaken at 30 oC, 250 rpm for another 2 
days. The 2rd round enrichment culture broth was diluted 104 times and spread 
on Rhodamine B olive oil plate and cultivated at 30 oC for 2 days. 
The colonies showing fluorescence haloes under UV light were picked, grown 
and then stored at -80 oC for further activity test towards amide bond 
formation. 
3.2.3.2 Methyl hexanoate as the sole carbon source  
Esterases, which prefer short chain length acyl donors compared with lipases, 
are also potential aminolyases. To cover all the possibilities, methyl hexanoate, 
a short chain carboxylic acid methyl ester, was thus utilized for isolating 
potential esterase producing strains.  
The detailed procedure for strain isolation is listed as follows: 
1 g of soil sample was added into 100 ml of sterilized DI water in a 250 ml 
shaking flask and the suspension was shaken at 30 oC, 250 rpm for 1 h. 10 ml 
of the supernatant was taken and inoculated into 100 ml M9 medium with 10 
mM of methyl hexanoate present and the suspension was shaken at 30 oC, 250 
rpm for 2 days. 10 ml of the 1st round enrichment culture broth was taken and 




hexanoate present and the culture was shaken at 30 oC, 250 rpm for another 2 
days. The 2rd round enrichment culture broth was diluted 104 times and spread 
on M9 plate with methyl hexanoate vapor as the sole carbon source and 
cultivated at 30 oC for 2 days. The colonies with different morphologies were 
picked, grown and stored at -80 oC for further activity test towards ester 
aminolysis. 
3.2.3.3 Octane or toluene as the sole carbon source  
In addition to triglycerides and short chain carboxylic esters, alkanes are also 
reported to be ideal stimulators for lipase or esterase expression in a number of 
wild type strains.187, 188, 189, 190. Based on this knowledge, octane and toluene 
were utilized as the sole carbon source for isolating potential aminolysis 
strains. 
The detailed procedure for isolating octane or toluene degrading strains is 
listed as follows: 
1 g of the soil sample was added into 100 ml of sterilized DI water in a 250 ml 
shaking flask and the suspension was shaken at 30 oC, 250 rpm for 1 h. 10 ml 
of the supernatant was taken and inoculated into 100 ml M9 medium with 10 
mM of octane or toluene present and the suspension was shaken at 30 oC, 250 
rpm for 2 days. 10 ml of the 1st round enrichment culture broth was taken and 
inoculated into another 100 ml fresh M9 medium with 10 mM of octane or 
toluene present and the suspension was shaken at 30 oC, 250 rpm for another 2 
days. The 2rd round enrichment culture broth was diluted 104 times and spread 
on M9 plate with octane or toluene vapor as the sole carbon source and 




picked, grown and stored at -80 oC for further activity test towards aminolyase 
activity. 
3.2.3.4 Activity screening 
The cells were grown in M9 medium with olive oil, methyl hexanoate, octane 
or toluene as the sole carbon source and inducer. After cell growth, the cells 
were harvested by centrifugation, washed with deionized water once and then 
subjected to activity test without further handling. 
200 mg wet cell pellet, 1 ml n-hexane, 10 mM methyl hexanoate 1c and 20 
mM n-pentylamine 2d were added into a 2 ml safe-lock tube and the reaction 
was performed on a mixing block at 30 °C, 1000 rpm for 1 day. 
After reaction, samples were centrifuged and the supernatant was taken 
directly for GC analysis for determining whether there was any N-
pentylhexanamide formation. Agilent 7890A gas chromatography equipped 
with a HP-5 capillary column (30 m × 322 μm, 0.25 μm) with inlet 
temperature of 280 oC and detector temperature of 300 oC was utilized to 
analyze N-pentylhexanamide. The temperature program used was: 40 oC keep 
for 1 min, then increase to 120 oC at a rate of 5 oC/ minute, then increase to 
250 oC at a rate of 10 oC/minute. The retention time for N-pentylhexanamide is 
23.025 min. 
3.2.4 Gene cloning 
The whole genome of Sphingomonas sp. HXN-200 has previously been 
sequenced within our lab and bioinformatic analysis showed that 11 putative 
lipases exist in a total number of 4544 genes.191 Primers were designed to 
amplify these 11 putative lipases from the genome by polymerase chain 




restriction enzymes and ligated to pRSFDuet-1 vector. The resulting plasmid 
was used to transform chemically competent T7 E. coli. 10 out of the 11 
putative lipases were successfully heterogously expressed in E. coli and 
showed activity for hydrolyzing p-nitrophenyl butyrate (PNPB). But only 1 
lipase (SpL) was found to be highly active for the target reaction, giving the 
corresponding N-pentylhexanamide in high yield. 
The whole genomic DNA of Sphingomonas sp. HXN-200 was prepared by 
using the DNeasy Blood & Tissue Kit and used as the PCR template. 
The following primers were used for amplifying SpL: 
Forward Primer: ACT GCA TAT GAC CGA CAG CAC GAC CCA TTA 
CAC 
(NdeI restriction site is underlined) 
Reverse Primer: ACT GAG ATC TTC ATG CCG CTC CGG TAG CCT CGG 
CG 
(BglII restriction site is underlined) 
To facilitate the purification of SpL, the following primers were used to 
engineer an N-terminally his-tagged SpL: 
Forward Primer: ACT GGG ATC CGA TGA CCG ACA GCA CGA CCC 
ATT ACA 
(BamHI restriction site is underlined) 
Reverse Primer: ACT GCT CGA GTC ATG CCG CTC CGG TAG CCT CGG 
CG 
(XhoI restriction site is underlined) 
PCRs were carried out using a Biorad MycyclerTM thermo cycler using the 




94 °C for 30 s, annealing at 72 °C for 30 s, extension at 72 °C for 45 s, total 33 
cycles, final extension at 72 °C for 10 min. 
PCR products were purified on 1% agarose gel in TAE buffer and then 
subjected to double digestion with appropriate restriction enzymes followed 
by ligation to pRSFDuet-1 vector. The ligation product was then used to 
transform T7 express competent E.coli cells and positive transformants were 
selected on LB agar plate containing 50 μg/ml of kanamycin. DNA 
sequencing confirmed the successful construction of the recombinant E.coli 
overexpressing SpL. 
3.2.5 Cell growth and protein expression 
E. coli (SpL) or E.coli (his-tagged SpL) was firstly grown in LB medium (2 ml) 
containing kanamycin (50 μg/ml) at 37 °C for 4-6 h and then inoculated into 
TB (Terrific Broth) medium (50 ml) containing kanamycin (50 μg/ml). When 
OD600 reached 0.6-0.8 (around 110 min), IPTG (0.25 mM) was added to 
induce the expression of protein. The cells were let to continue growing for 
14−16 h at 22 °C and the cell density reached 6.4-7.2 g cdw/L. The cells were 
then harvested by centrifugation (5000 g, 5 min), washed with deionized water 
once and used for activity test or protein purification without further handling.  
3.2.6 Activity test 
P-nitrophenyl butyrate (PNPB) was used as the model substrate for activity 
test. Freshly prepared E. coli (SpL) cells were diluted by KP buffer (100 mM, 
pH 7.5) to 0.5 g cdw/L cell density. The cells were then lysed with a 
homogenizer and spun down on a centrifuge to remove the cell debris. The 
cell free extract was diluted with KP buffer (100 mM, pH 7.5) to a proper 




range for measurement and 10 ul of the diluted cell free extract was added to 
990 ul of KP buffer (100 mM, pH 7.5) and mixed well. Then 10 ul of 50 mM 
PNPB acetonitrile solution was added and the absorption at 400 nm was 
monitored by a photometer. The specific activity was calculated according to 
the following equation: 
units mg⁄ cdw =
(∆A400nm min test⁄ − ∆A400nm minblank⁄ )(df)(1000)
(0.0148)(0.01ml)(mg	cdw/ml	enzyme)
 
df = dilution factor 
0.0148 = micromolar extinction coefficient of p-nitrophenol at 400 nm 
0.01 = volume (in milliliter) of enzyme used 
3.2.7 Purification of his-tagged SpL 
The cells were resuspended in KP buffer (10 mM, pH 8.0) to OD600=40 and 
then let pass through a cell homogeniser (Stansted fluid power LTD) twice, 
followed by centrifugation (23000 g, 4 oC) for 50 min to remove the cell 
debris. The cell free extract was filtered with 0.2 μm Supor® membranes to 
remove small particles present and then subjected to FPLC for protein 
purification. 
A single step affinity chromatography was used for purification. The IMAC 
(immobilized metal affinity chromatography) was performed on an AKTA 
purifier with a HisPrep FF 16/10 column to remove most of the impurities. To 
monitor the purification process, the total protein present in the solution was 
monitored by setting the detector wavelength at 280 nm. The temperature was 
kept at 4 oC for the whole process.  
The cell free extract was loaded onto the histrap column manually with a 
syringe. The column was then washed with a wash buffer (20 mM sodium 




the 280 nm absorption value, a wash buffer (20 mM sodium phosphate, 500 
mM NaCl, pH 7.4, 300 mM imidazole) was used to elute the target protein. 
The salts and imidazole present in the enzyme solution were removed by 
diafiltering the protein solution with deionized water in an Amicon Ultra-15 
Centrifugal Filter Units (20 kD). 
After purification, the protein concentration was measured by Bradford assay. 
Protein purity was checked by SDS-PAGE. 
3.2.8 Sample preparation for SDS-PAGE 
For analyzing the protein expression level, the cells were firstly harvested by 
centrifugation and then diluted to OD600 of 10 with DI water. The cells were 
then lysed with a homogenizer (Stansted fluid power LTD) twice and 
centrifuged to get the cell free extract (CFE). The CFE was then mixed with 
2×SDS loading buffer (100 mM Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 25% 
β-mercaptoethanol, 0.05% bromophonol blue) at a volume ratio of 1:1, heated 
at 95 oC for 5 min and then subjected to SDS-PAGE analysis. 
For analyzing the protein purity, the protein solution was firstly diluted to a 
concentration of 1 mg/ml and then mixed with 2×SDS loading buffer at a 
volume ratio of 1:1, heated to 95 oC for 5 min and then subjected to SDS-
PAGE analysis. 
3.2.9 Product analysis method 
3a-3g and 3q-3s were analyzed on a Shimadzu prominence HPLC system 
(LC-20AD, normal phase) equipped with a Diacel Chiralpak IA-3 column 
(250 × 4.6 mm, 3 μm). The UV detection wavelength was set at 210 nm. Oven 
temperature was set at 25 oC. The mobile phase consisted of a mixture of n-




Table 3.2 HPLC analysis conditions and the analysis results for 3a-3g and 3q-
3s 
 
Product RT n-hexane: isopropanol 
3a 16.3 min 90: 10 
3b 9.1 min 90: 10 
3c 7.8 min 90: 10 
3d 11.2 min 90: 10 
3e 11.3 min 90: 10 
3f 9.9 min 90: 10 
3g 6.9 min 90: 10 
(R)-3q 13.2 min 
90: 10 
(S)-3q 19.4 min 
(R)-3r 10.9 min 
95: 5 
(S)-3r 13.1 min 
(R)-3s 8.4 min 
90: 10 
(S)-3s 10.6 min 
 
3h-3p and 3t were analyzed on a Shimadzu prominence HPLC system (LC-
20AD, reverse phase) equipped with a BC-Poroshell 120 SB-Aq column 
(100×4.6 mm, 2.7 μm). The UV detection wavelength was set at 210 nm. The 
oven temperature was set at 25 oC. The mobile phase consisted of a mixture of 
water and acetonitrile with 0.1% of trifluoroacetic acid present at a flow rate 
of 0.8 ml/min. 
Table 3.3 HPLC analysis conditions and the analysis results for 3h-3p and 3t 
 
Product RT Water: Acetonitrile 
3h 6.9 min 95:5 
3i 13.2 min 95:5 
3j 22.4 min 95:5 
3k 11.9 min 95:5 
3l 18.8 min 95:5 
3m 16.9 min 90:10 
3n 16.5 min 85:15 
3o 10.9 min 90:10 
3p 6.2 min 98:2 






3.2.10 General procedure for aminolysis of esters with free SpL, free 
CALB or Novozyme 435 
Preparation of free CALB: the glycerol and salts inside the commercially 
available CALB solution from SPRIN were removed by washing the enzyme 
solution with deionized water in an Amicon Ultra-15 Centrifugal Filter Units 
(20 kD). The pure enzyme powder was acquired by lyophilizing the enzyme 
solution for at least 24 h. 
10 mg of free SpL, free CALB or Novozyme 435 (immobilized CALB) was 
added to a 10 ml shaking flask. 5 ml of n-hexane, 200 ul of deionized water 
(for SpL), 200 mg activated 4A molecular sieve powder (for CALB and 
Novozyme 435), 20 mM of amine were then added and the reaction mixture 
was equilibrated by shaking in an incubator at 30 °C, 250 rpm for 5 min. Then 
10 mM of appropriate ester was added and the reaction was performed by 
shaking the reaction mixture in an incubator at 30 °C, 250 rpm for 30 min (for 
measuring the initial reaction rate or final amide yield) and 20 h (for 
measuring the final amide yield). 
For analysing 3a-3g and 3q-3s, after reaction, 5 ml of tert butyl methyl ether 
(MTBE) was added for dissolving any possibly insoluble amides and 
anhydrous sodium sulphate was added to remove water. 1 ml aliquot was 
removed for HPLC analysis. Analytic samples were prepared by 
centrifugation, and then 200 ul of supernatant was mixed with 200 ul MTBE 
(2 mM benzyl alcohol as internal standard) before HPLC analysis for 
quantification of ee and concentration of the amides. 
For analysing 3h-3p and 3t, after reaction, n-hexane was removed by 




any possibly insoluble amides. 1 ml aliquot was removed for HPLC analysis. 
Analytic samples were prepared by centrifugation, and then 200 ul of 
supernatant was mixed with 200 ul methanol (2 mM 1-phenylethanol as 
internal standard) before HPLC analysis for quantification of the concentration 
of the amides. 
3.2.11 General procedure for aminolysis of esters with wet cells of E. coli 
(SpL) 
Wet cell pellet of E.coli (SpL) (926.7 mg) was added to a 10 ml round bottom 
flask. 5 ml of n-hexane and a specific concentration of amine were then added 
and the reaction mixture was stirred with a magnetic stirrer at 30 °C, 1400 rpm 
for 5 min. At this point a specific concentration of the appropriate ester was 
added and the reaction mixture was stirred with a magnetic stirrer at 30 °C, 
500 rpm for 30 min (for measuring the initial reaction rate) or appropriate time 
(for measuring the final amide yield).  
After reaction, 5 ml of chloroform was added to dissolve any possibly 
insoluble amide and anhydrous sodium sulphate was added to remove water. 
Aliquot (1 ml) was removed for HPLC analysis. Analytic samples were 
prepared by centrifugation, and then mixing 100 ul of the supernatant with 900 
ul of chloroform. 200 ul of this diluted sample was then mixed with 200 ul of 
MTBE (2 mM benzyl alcohol as internal standard) before HPLC analysis for 
quantification of ee and concentration of the amides. 
3.2.12 Preparation of 3b, 3c and 3d with wet cells of E.coli (SpL) 
4.6 g freshly prepared wet cells of E.coli (SpL) were added to 25 ml n-hexane 
in a 100 ml round bottom flask. A specific concentration of amine was added 




30 °C, 500 rpm for 5 min. Then a specific concentration of corresponding 
ester or carboxylic acid was added and the reaction was performed while 
mixing with the mixing propeller at 30 °C, 500 rpm for 2 h. After reaction, 25 
ml of chloroform was added for dissolving any possibly insoluble amide and 
anhydrous sodium sulphate was added to remove water. The cells were 
removed by filtration. Crude products were acquired by removing the solvent 
by evaporation. The crude products were purified by column chromatography 
on silica gel (n-hexane: ethyl acetate=10:1 for 3b; n-hexane: ethyl acetate=5:1 
for 3c and 3d). 
 
3b: obtained as a white solid; yield: 91%; 1H NMR (400 MHz, CDCl3, TMS): 
δ 7.35-7.25 (m, 5H), 5.72 (s, br, 1H), 4.44 (d, J = 5.6 Hz, 2H), 2.11 (tt, J = 
11.8, 3.5 Hz, 1H), 1.91-1.66 (m, 5H), 1.51-1.42 (m, 2H), 1.31-1.19 (m, 3H). 
13C NMR (100 MHz, CDCl3, TMS): δ 175.9, 138.5, 128.7, 127.7, 127.4, 45.6, 
43.4, 29.7, 25.7. TOFMS-ESI (m/z): (M+H)+, (M+Na)+ and (M+Na+ACN)+ 
calculated for C14H19NO, 218.154, 240.136 and 281.163; Found, 218.154, 













Figure 3.2 a) 1H NMR spectrum of 3b; b) 13C NMR spectrum of 3b; c) 
HRMS spectrum of 3b. 
 
3c: obtained as a white solid; yield: 90%; 1H NMR (400 MHz, CDCl3, TMS): δ 
7.35-7.25 (m, 5H), 5.75 (s, br, 1H), 4.44 (d, J = 5.6 Hz, 2H), 2.20 (t, J = 7.2 
Hz, 2H), 1.66 (p, J = 7.6 Hz, 2H), 1.33-1.29 (m, 4H), 0.89 (t, J = 6.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3, TMS): δ 173.0, 138.4, 128.7, 127.8, 127.5, 43.6, 
36.8, 31.5, 25.4, 22.4, 13.9. TOFMS-ESI (m/z): (M+H)+, (M+Na)+ and 
(M+Na+ACN)+ calculated for C13H19NO, 206.154, 228.136, 269.163; Found, 













Figure 3.3 a) 1H NMR spectrum of 3c; b) 13C NMR spectrum of 3c; c) HRMS 






3d: obtained as a white solid; yield: 94% 1H NMR (400 MHz, CDCl3, TMS): δ 
7.32-7.26 (m, 5H), 7.23-7.14 (m, 5H), 5.62 (s, br, 1H), 4.40 (d, J = 5.7 Hz, 
2H), 3.00 (t, J = 7.6 Hz, 2H), 2.52 (t, J = 7.6 Hz, 2H). 13C NMR (100 MHz, 
CDCl3, TMS): δ 171.8, 140.7, 138.1, 128.6, 128.5, 128.4, 127.7, 127.4, 126.2, 
43.6, 38.5, 31.7. TOFMS-ESI (m/z): (M+H)+ and (M+Na)+ calculated for 

















Figure 3.4 a) 1H NMR spectrum of 3d; b) 13C NMR spectrum of 3d; c) 
HRMS spectrum of 3d. 
3.2.13 Preparation of substrates and product standards 
3.2.13.1 Preparation of substrates 
Preparation of methyl 1H-pyrazole-3-carboxylate 1e 
Methyl 1H-pyrazole-3-carboxylate 1e was synthesized by esterification of 1H-
pyrazole-3-carboxylic acid 4b with methanol under Fischer conditions.  
4 g 1H-pyrazole-3-carboxylic acid 4b, 50 ml methanol and 4 ml H2SO4 (98%) 
were added to a 100 ml round bottom flask. The mixture was stirred with a 
magnetic stirrer at room temperature, 500 rpm for 48 h. After reaction, sodium 
bicarbonate was added to quench the excess H2SO4 and chloroform (50 ml × 3) 
was added to extract methyl 1H-pyrazole-3-carboxylate 1e. The chloroform 
layer was combined, washed with saturated NaHCO3 solution for 3 times and 
DI water for 1 time and then dried over anhydrous sodium sulfate, filtered and 
evaporated to get methyl 1H-pyrazole-3-carboxylate 1e as a white solid. 
3.2.13.2 Preparation of product standards 
3a-3g and 3q-3s were synthesized by using Novozyme 435 as the catalyst for 







and 3t were synthesized either through an acid chloride intermediate or the 
direct condensation of the corresponding carboxylic acid and amine under the 
mediation of EDCI and HOBT. 
All the amide standards were purified by either column chromatography with 
Merck silica gel 60 (200–300 mesh) as the stationary phase or recrystallizaiton 
in appropriate solvent. TLC was carried out with pre-coated Silica Gel 60 
F254 TLC-plate from Merck and compounds were visualized with UV light. 
Preparation of N-benzylbenzamide 3a 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl benzoate 
1a (272.3 mg, 2 mmol), benzylamine 2a (321.5 mg, 3 mmol), 20 ml MTBE 
and 2 g activated molsieve 4A (powder, 325 mesh) were then added and the 
mixture was shaken at 50 oC for 24 h. After reaction, Novozyme 435 and 
molsieve 4A were filtered off and the solvent was removed by evaporation. 
The crude product was purified by column chromatography on silica gel (n-
hexane: ethyl acetate=10:1, Rf≈0.3). N-benzylbenzamide 3a was obtained as a 
white solid.  
Preparation of N-benzylcyclohexanecarboxamide 3b 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl 
cyclohexanecarboxylate 1b (284.4 mg, 2 mmol), benzylamine 2a (321.5 mg, 3 
mmol), 20 ml MTBE and 2 g activated molsieve 4A were then added and the 
mixture was shaken at 50 oC for 24 h. After reaction, Novozyme 435 and 
molsieve 4A were filtered off and the solvent was removed by evaporation. 
The crude product was purified by column chromatography on silica gel (n-
hexane: ethyl acetate=10:1, Rf≈0.3). N-benzylcyclohexanecarboxamide 3b was 




Preparation of N-benzylhexanamide 3c 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl hexanoate 
1c (260.4 mg, 2 mmol), benzylamine 2a (321.5 mg, 3 mmol), 20 ml MTBE 
and 2 g activated molsieve 4A were then added and the mixture was shaken at 
50 oC for 24 h. After reaction, Novozyme 435 and molsieve 4A were filtered 
off and the solvent was removed by evaporation. The crude product was 
purified by column chromatography on silica gel (n-hexane: ethyl acetate=5:1, 
Rf≈0.3). N-benzylhexanamide 3c was obtained as a white solid.  
Preparation of N-benzylbenzenepropanamide 3d 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl 3-
phenylpropionate 1d (328.4 mg, 2 mmol), benzylamine 2a (321.5 mg, 3 
mmol), 20 ml MTBE and 2 g activated molsieve 4A were then added and the 
mixture was shaken at 50 oC for 24 h. After reaction, Novozyme 435 and 
molsieve 4A were filtered off and the solvent was removed by evaporation. 
The crude product was purified by column chromatography on silica gel (n-
hexane: ethyl acetate=5:1, Rf≈0.3). N-benzylbenzenepropanamide 3d was 
obtained as a white solid.  
Preparation of N-phenylbenzenepropanamide 3e 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl 3-
phenylpropionate 1d (328.4 mg, 2 mmol), aniline 2b (279.4 mg, 3 mmol), 20 
ml MTBE and 2 g activated molsieve 4A were then added and the mixture was 
shaken at 50 oC for 24 h. After reaction, Novozyme 435 and molsieve 4A were 
filtered off and the solvent was removed by evaporation. The crude product 




acetate=10:1, Rf≈0.3). N-phenylbenzenepropanamide 3e was obtained as a 
white solid.  
Preparation of N-(2-phenylethyl)benzenepropanamide 3f 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl 3-
phenylpropionate 1d (328.4 mg, 2 mmol), phenethylamine 2c (363.5 mg, 3 
mmol), 20 ml MTBE and 2 g activated molsieve 4A were then added and the 
mixture was shaken at 50 oC for 24 h. After reaction, Novozyme 435 and 
molsieve 4A were filtered off and the solvent was removed by evaporation. 
The crude product was purified by column chromatography on silica gel (n-
hexane: ethyl acetate=2:1, Rf≈0.3). N-(2-phenylethyl)benzenepropanamide 3f 
was obtained as a white solid.  
Preparation of N-pentylbenzenepropanamide 3g 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl 3-
phenylpropionate 1d (328.4 mg, 2 mmol), n-pentylamine 2d (261.5 mg, 3 
mmol), 20 ml MTBE and 2 g activated molsieve 4A were then added and the 
mixture was shaken at 50 oC for 24 h. After reaction, Novozyme 435 and 
molsieve 4A were filtered off and the solvent was removed by evaporation. 
The crude product was purified by column chromatography on silica gel (n-
hexane: ethyl acetate=8:1, Rf≈0.3). N-pentylbenzenepropanamide 3g was 
obtained as a white solid. 
Preparation of (rac)-α-hydroxy-N-(phenylmethyl)benzeneacetamide 3q 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. (rac)-methyl 
mandelate (rac)-1g (332.3 mg, 2 mmol), benzylamine 2a (321.5 mg, 3 mmol), 
20 ml MTBE and 2 g activated molsieve 4A were then added and the mixture 




were filtered off and the solvent was removed by evaporation. The crude 
product was purified by column chromatography on silica gel (n-hexane: ethyl 
acetate=2:1, Rf≈0.3). (rac)-α-hydroxy-N-(phenylmethyl)benzeneacetamide 3h 
was obtained as a white solid.  
Preparation of (rac)-N-(1-cyclohexylethyl)benzenepropanamide 3r 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl 3-
phenylpropionate 1d (492.6 mg, 3 mmol), (R)-(-)-1-cyclohexylethylamine (R)-
2j (127.3 mg, 1 mmol), (S)-(+)-1-cyclohexylethylamine (S)-2j (127.3 mg, 1 
mmol), 20 ml MTBE and 2 g activated molsieve 4A were then added and the 
mixture was shaken at 50 oC for 24 h. After reaction, Novozyme 435 and 
molsieve 4A were filtered off and the solvent was removed by evaporation. 
The crude product was purified by column chromatography on silica gel (n-
hexane: ethyl acetate=5:1, Rf≈0.3). (rac)-N-(1-cyclohexylethyl)
benzenepropanamide 3r was obtained as a white solid.  
Preparation of (rac)-N-(1-phenylethyl)benzenepropanamide 3s 
Novozyme 435 (1.2 g) was added to a 50 ml shaking flask. Methyl 3-
phenylpropionate 1d (492.6 mg, 3 mmol), α-methylbenzylamine 2k (242.4 mg, 
2 mmol), 20 ml MTBE and 2 g activated molsieve 4A were then added and the 
mixture was shaken at 50 oC for 24 h. After reaction, Novozyme 435 and 
molsieve 4A were filtered off and the solvent was removed by evaporation. 
The crude product was purified by column chromatography on silica gel (n-
hexane: ethyl acetate=2:1, Rf≈0.3). (rac)-N-(1-phenylethyl)






Preparation of N-1H-pyrazol-3-yl-1H-pyrazole-3-carboxamide 3h 
1H-pyrazole-3-carboxylic acid 4b (1 g, 8.92 mmol) and THF (8 ml) were 
added in to a 50 ml round bottom flask. The mixture was cooled to 0 oC by 
incubating on an ice water bath for 30 min. 4 ml thionyl chloride was added 
dropwise at 0 oC. The reaction mixture was then heated up to 70 oC and 
refluxed at this temperature for 1 h. THF and excess thionyl chloride were 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(3.1 ml, 22.24 mmol) and 3-aminopyrazole 2e (741.2 mg, 8.92 mmol) were 
then added and mixture was stirred with a magnetic stirrer at room 
temperature overnight. After reaction, DMF was removed by evaporating. 
Chloroform (50 ml × 3) was added to extract the product. The chloroform 
layer was combined and washed with saturated NaHCO3 solution (50 ml × 3) 
and 0.1 N HCl solution (50 ml × 3). The crude product was acquired by 
evaporating chloroform. Pure product was acquired by recrystallization of the 
crude product in ethyl acetate and methanol.  
Preparation of N-(1,3-dimethyl-1H-pyrazol-5-yl)-1H-pyrazole-3-
carboxamide 3i 
1H-pyrazole-3-carboxylic acid 4b (1 g, 8.92 mmol) and THF (8 ml) were 
added in to a 50 ml round bottom flask. The mixture was cooled to 0 oC by 
incubating on an ice water bath for 30 min. 4 ml thionyl chloride was added 
dropwise at 0 oC. The reaction mixture was then heated up to 70 oC and 
refluxed at this temperature for 1 h. THF and excess thionyl chloride were 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(3.1 ml, 22.24 mmol) and 5-amino-1, 3-dimethylpyrazole 2f (991.5 mg, 8.92 




room temperature overnight. DMF was removed by evaporating. Chloroform 
(50 ml × 3) was added to extract the product. The chloroform layer was 
combined and washed with saturated NaHCO3 solution (50 ml × 3) and 0.1 N 
HCl solution (50 ml × 3). The crude product was acquired by evaporating 
chloroform. Pure product was acquired by recrystallization of the crude 
product in ethyl acetate and methanol.  
Preparation of N-(5-methyl-3-isoxazolyl)-1H-pyrazole-3-carboxamide 3j 
1H-pyrazole-3-carboxylic acid 4b (1 g, 8.92 mmol) and THF (8 ml) were 
added in to a 50 ml round bottom flask. The mixture was cooled to 0 oC by 
incubating on an ice water bath for 30 min. 4 ml thionyl chloride was added 
dropwise at 0 oC. The reaction mixture was then heated up to 70 oC and 
refluxed at this temperature for 1 h. THF and excess thionyl chloride were 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(3.1 ml, 22.24 mmol) and 3-amino-5-methylisoxazole 2g (875.1 mg, 8.92 
mmol) were then added and mixture was stirred with a magnetic stirrer at 
room temperature overnight. DMF was removed by evaporating. Chloroform 
(50 ml × 3) was added to extract the product. The chloroform layer was 
combined and washed with saturated NaHCO3 solution (50 ml × 3) and 0.1 N 
HCl solution (50 ml × 3). The crude product was acquired by evaporating 
chloroform. Pure product was acquired by recrystallization of the crude 
product in n-hexane and ethyl acetate.  
Preparation of N-(1H-benzimidazol-2-ylmethyl)-1H-pyrazole-3-
carboxamide 3k 
1H-pyrazole-3-carboxylic acid 4b (1 g, 8.92 mmol) and THF (8 ml) were 




incubating on an ice water bath for 30 min. 4 ml thionyl chloride was added 
dropwise at 0 oC. The reaction mixture was then heated up to 70 oC and 
refluxed at this temperature for 1 h. THF and excess thionyl chloride were 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(5.6 ml, 40.18 mmol) and 2-(aminomethyl)benzimidazole dihydrochloride 2h 
(1.963 g, 8.92 mmol) were then added and mixture was stirred with a magnetic 
stirrer at room temperature overnight. DMF was removed by evaporating. 
Chloroform (50 ml × 3) was added to extract the product. The chloroform 
layer was combined and washed with saturated NaHCO3 solution (50 ml × 3) 
and 0.1 N HCl solution (50 ml × 3). The crude product was acquired by 
evaporating chloroform. Pure product was acquired by recrystallization of the 
crude product in ethyl acetate and methanol.  
Preparation of N-1H-pyrazol-3-yl-2-pyridinecarboxamide 3l 
2-picolinic acid 4c (1.098 g, 8.92 mmol) was added to a 50 ml round bottom 
flask. The system was cooled to 0 oC by incubating on an ice water bath for 30 
min. Thionyl chloride (10 ml) and DMF (0.1 ml) were then added dropwise at 
0 oC. The mixture was refluxed at 70 oC for 2 h. Excess thionyl chloride was 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(3.1 ml, 22.24 mmol) and 3-aminopyrazole 2e (741.2 mg, 8.92 mmol) were 
then added and mixture was stirred with a magnetic stirrer at room 
temperature overnight. DMF was removed by evaporating. Chloroform (50 ml 
× 3) was added to extract the product. The chloroform layer was combined and 
washed with saturated NaHCO3 solution (50 ml × 3) and 0.1 N HCl solution 




product was acquired by recrystallization of the crude product in ethyl acetate 
and methanol.  
Preparation of N-(1,3-dimethyl-1H-pyrazol-5-yl)-2-pyridinecarboxamide 
3m 
2-picolinic acid 4c (1.098 g, 8.92 mmol) was added to a 50 ml round bottom 
flask. The system was cooled to 0 oC by incubating on an ice water bath for 30 
min. Thionyl chloride (10 ml) and DMF (0.1 ml) were then added dropwise at 
0 oC. The mixture was refluxed at 70 oC for 2 h. Excess thionyl chloride was 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(3.1 ml, 22.24 mmol) and 5-amino-1, 3-dimethylpyrazole 2f (991.5 mg, 8.92 
mmol) were then added and mixture was stirred with a magnetic stirrer at 
room temperature overnight. DMF was removed by evaporating. Chloroform 
(50 ml × 3) was added to extract the product. The chloroform layer was 
combined and washed with saturated NaHCO3 solution (50 ml × 3) and 0.1 N 
HCl solution (50 ml × 3). The crude product was acquired by evaporating 
chloroform. Pure product was acquired by recrystallization of the crude 
product in n-hexane and ethyl acetate.  
Preparation of N-(5-methyl-3-isoxazolyl)-2-pyridinecarboxamide 3n 
2-picolinic acid 4c (1.098 g, 8.92 mmol) was added to a 50 ml round bottom 
flask. The system was cooled to 0 oC by incubating on an ice water bath for 30 
min. Thionyl chloride (10 ml) and DMF (0.1 ml) were then added dropwise at 
0 oC. The mixture was refluxed at 70 oC for 2 h. Excess thionyl chloride was 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(3.1 ml, 22.24 mmol) and 3-amino-5-methylisoxazole 2g (875.1 mg, 8.92 




room temperature overnight. DMF was removed by evaporating. Chloroform 
(50 ml × 3) was added to extract the product. The chloroform layer was 
combined and washed with saturated NaHCO3 solution (50 ml × 3) and 0.1 N 
HCl solution (50 ml × 3). The crude product was acquired by evaporating 
chloroform. Pure product was acquired by recrystallization of the crude 
product in n-hexane and ethyl acetate.  
Preparation of N-(1H-benzimidazol-2-ylmethyl)-2-pyridinecarboxamide 
3o 
2-picolinic acid 4c (1.098 g, 8.92 mmol) was added to a 50 ml round bottom 
flask. The system was cooled to 0 oC by incubating on an ice water bath for 30 
min. Thionyl chloride (10 ml) and DMF (0.1 ml) were then added dropwise at 
0 oC. The mixture was refluxed at 70 oC for 2 h. Excess thionyl chloride was 
removed by evaporating in a rotary evaporator. DMF (10 ml), triethylamine 
(5.6 ml, 40.18 mmol) and 2-(aminomethyl)benzimidazole dihydrochloride 2h 
(1.963 g, 8.92 mmol) were then added and mixture was stirred with a magnetic 
stirrer at room temperature overnight. DMF was removed by evaporating. 
Chloroform (50 ml × 3) was added to extract the product. The chloroform 
layer was combined and washed with saturated NaHCO3 solution (50 ml × 3) 
and 0.1 N HCl solution (50 ml × 3). The crude product was acquired by 
evaporating chloroform. Pure product was acquired by recrystallization of the 
crude product in ethyl acetate and methanol. 
Preparation of 4-(1H-pyrazol-3-ylcarbonyl)-2-piperazinone 3p 
1H-pyrazole-3-carboxylic acid 4b (461.8 mg, 4.12 mmol) and 
dichloromethane (50 ml) were added to a 100 ml round bottom flask and the 




EDCI (920.2 mg, 4.8 mmol), HOBT (805 mg, 5.2 mmol) and triethylamine 
(2.5 ml, 17.9 mmol) were then added and the mixture was stirred at 0 oC, 250 
rpm for 30 min. 2-oxopiperazine 2i (400.5 mg, 4 mmol) was then added and 
the mixture was stirred at room temperature overnight. The crude product was 
acquired by evaporating dichloromethane. The pure amide was acquired by 
column chromatography on silica gel (ethyl acetate: methanol=10:3, Rf≈0.3). 
4-(1H-pyrazol-3-ylcarbonyl)-2-piperazinone 3p was obtained as a dark yellow 
solid. TOFMS-ESI (m/z): (M+H)+ calculated for C8H10N4O2, 195.088; Found, 
195.084. 
 
Figure 3.5 Mass spectroscopy of the purified 3p by column chromatography 




1H-pyrazole-3-carboxylic acid 4b (461.8 mg, 4.12 mmol) and 
dichloromethane (50 ml) were added to a 100 ml round bottom flask and the 
mixture was cooled to 0 oC by incubating on an ice water bath for 30 min. 
EDCI (920.2 mg, 4.8 mmol), HOBT (805 mg, 5.2 mmol) and triethylamine 
(2.5 ml, 17.9 mmol) were then added and the mixture was stirred at 0 oC, 250 
rpm for 30 min. 1-boc-piperazine 2l (745 mg, 4 mmol) was then added and the 




mixture was stirred at room temperature overnight. The reaction mixture was 
washed with saturated NaHCO3 solution (50 ml×3), dried over anhydrous 
sodium sulphate, filtered and evaporated to get 1-(1H-pyrazol-3-ylcarbonyl)-
4-(tert-butoxycarbonyl)piperazine 3t as a white solid.  
3.3 Results and discussion 
3.3.1 Strain screening 
Strain screening is normally the first step of developing a biocatalytic process.  
For fast and reliable identification of lipase producing strains, a series of 
efficient screening strategies have been developed. For example, the use of 
triglycerides such as olive oil as the sole carbon source for enrichment culture 
followed by using Rhodamine B as an indicator for high-throughput screening 
of lipase activity proved to be a highly effective way to discover novel 
lipases.192 
For screening of aminolyases, this strategy, however, suffers one major 
drawback since a number of potentially useful esterases can easily keep silent 
when only triglycerides are used as the inducers. 
In this study, except for using olive oil as the sole carbon source for 
enrichment culture, methyl hexanoate, n-octane and toluene were applied to 
increase the diversity of the microorganism library created and to increase the 
chance of getting the positive hits.  











Table 3.4 Strain screening summary 
 
Strain origin 
Number of strains 
screened 
Number of 
positive strains a 
Strain classification 








Octane 40 1 
Sphingomonas sp. 
HXN-200 b 
Toluene 60 1 Bacillus sp. ATOL-1 
 
a The positive strain means the wet cells of the strain showed catalytic activity 
for aminolysis of methyl hexanoate with n-pentylamine. 
b This strain was isolated by our lab previously. 
The 4 positive strains isolated showed high activities for aminolysis of methyl 
hexanoate with n-pentylamine. All of them gave amide yield more than 40% 
after 24 h of reaction. It is worthwhile to note that Sphingomonas sp. HXN-
200 gave the highest amide yield of 78.6% after 24 h of reaction and a 
noticeable specific activity of 0.055 U/g cww, demonstrating that it possesses 
outstanding aminolyase which is worthwhile to investigate further. 
Although the 4 wild-type strains isolated showed high activities for ester 
aminolysis, direct application of them for amide synthesis is not practical. On 
one hand, the wild-type strains are difficult to grow. Sole carbon source has to 
be supplied in a salt minimum medium to induce the target enzyme expression, 
which leads to a significantly slow cell growth speed and low cell yield. Not to 
mention that methyl hexanoate, octane and toluene are volatile and flammable 
chemicals, this causes potential safety issues. On the other hand, the 
expression level of the target functioning enzymes present in these series of 
wild-type strains is low, which cannot satisfy real synthetic applications. Thus, 
engineering a highly active and readily-available whole cell biocatalyst by 




and heterologous expression of the target enzymes in E. coli was highly 
desirable. 
Table 3.5 Aminolysis of methyl hexanoate with n-pentylamine by the 4 
positive strains isolated 
 
Strain Time (h) Amide yield (%) a 
Specific activity 
(U/g cww) b 
Rhodococcus sp. 
MHD-246 
24 55.8 0.039 
Rhodococcus sp. 
MHD-280 
24 73.0 0.051 
Bacillus sp. ATOL-1 24 41.2 0.029 
Sphingomonas sp. 
HXN-200 
24 78.6 0.055 
 
The reaction was performed with 10 mM of methyl hexanoate and 20 mM of 
n-pentylamine in 1 ml n-hexane with 200 mg of wet cell pellet of the isolated 
strain for 24 h. 
a Amide yield was calculated according to the following equation: (peak area 
of N-pentylhexanamide)/(peak area of N-pentylhexanamide + peak area of 
methyl hexanoate + peak area of n-pentylamine) 
b Specific activity was calculated based on the cell wet weight and the amide 
concentration at 24 h. cww represents cell wet weight. 
 
3.3.2 Genetic engineering of recombinant E. coli overexpressing SpL 
Cloning of the functioning enzymes present in all of isolated 4 wild-type 
strains was performed. Since the whole genome sequence of Rhodococcus sp. 
MHD-246, Rhodococcus sp. MHD-280 and Bacillus sp. ATOL-1 was not 
known, the whole genome sequence of Rhodococcus erythropolis Moj, 
Rhodococcus equi EB-8-4 and Bacillus cereus ATCC 14579 was used as the 
reference (since the 16s rDNA alignment showed these 3 isolated strains are 
most related to these 3 reference strains) and several potential lipases were 
cloned and heterogeneously expressed in E.coli. Unfortunately, none of the 





Figure 3.6 a) Cell growth and specific activity for the hydrolysis of PNPB of 
E. coli (SpL). ■: cell density; ▲: specific activity. Cells were initially grown 
at 37 °C, induced by the addition of IPTG (0.25 mM) at 1 h 50 min, and then 
grown at 22 °C. b) SDS-PAGE. Lane 1: Marker. Lane 2: Cell free extract of E. 
coli (SpL). Lane 3: Marker. Lane 4: Purified his-tagged Sto-Est. Lane 5: 
purified his-tagged SpL. Lane 6: purified his-tagged SpL (A190G). c) Effect 
of water content on aminolysis of 10 mM methyl hexanoate with 20 mM 
benzylamine catalyzed by free SpL in n-hexane. The water concentration is on 
v/v basis. Specific activity was calculated after 30 min. Final amide yield was 
determined after 20 h. For the 0% case, 200 mg of activated 4A molsieve was 
added to ensure totally anhydrous condition. □: Specific activity (U/g protein); 
■: Final amide yield (%). d) Effect of water content on the E. coli (SpL) 
catalyzed aminolysis of 100 mM methyl hexanoate with 120 mM benzylamine 
in n-hexane. The water concentration is on v/v basis. Specific activity was 
calculated after 30 min. Final amide yield was determined after 20 h. For the 0% 
case, 200 mg of activated 4A molsieve was added to ensure totally anhydrous 
condition. □: Specific activity (U/g cdw); ■: Final amide yield (%). 
 
The whole genome of Sphingomonas sp. HXN-200 has previously been 
sequenced in our lab and sequence analysis with interpretation provided by 
KEGG, COG, SwissProt, TrEMBL and NR databases showed that 11 putative 





amplified by polymerase chain reaction (PCR) with appropriate primers. The 
PCR products were purified by using a Thermo scientific gel extraction kit and 
then subjected to double digestion with appropriate enzymes before being 
ligated to the pRSFDuet-1 plasmid (Novagen). The resultant plasmids were 
used to transform chemically competent T7 E. coli (New England Biolabs) to 
yield recombinant E. coli for protein expression and activity test. 10 out of 
these 11 putative lipases were successfully heterogously expressed in E. coli 
and showed activity for hydrolyzing p-nitrophenyl butyrate (PNPB). But only 
1 lipase (SpL) was found to be highly active for the target reaction giving the 
corresponding N-pentylhexanamide in high yield. 
The gene of SpL consists of 948 bp, encoding a 315 amino acid protein with a 
predicted molecular weight of 33.81 kDa. A BLASTP search of the NCBI 
protein database showed that SpL shares most similarity with an alpha/beta 
hydrolase fold-3 protein from Sphingopyxis alaskensis RB2256 and the amino 
acid identity is 86%. No study on this alpha/beta hydrolase fold-3 protein from 
Sphingopyxis alaskensis RB2256 suggests that SpL is a novel enzyme. 
The recombinant E. coli synthesizing SpL is easy to cultivate in TB (Terrific 
Broth) medium. As shown in Figure 3.6 a, a cell density of 6.4-7.2 g cdw/L 
was achieved between 16-20 h. Cells taken at different time points showed 
different specific activity towards the hydrolysis of p-nitrophenyl butyrate 
(PNPB). The highest specific activity (350 U/mg cdw) was achieved between 
16-18 h, when the stationary phase just initiated. The expression of SpL was 
clearly shown on the SDS-PAGE of the CFE (cell free extract) of the E. coli 




Aminolysis of methyl 3-phenylpropionate 1d with α-methylbenzylamine 2k 
was used as a model reaction to test the specific activity of E. coli (SpL) and a 
high specific activity of 8.2 U/g cdw was detected, which is 167 times higher 
than that of the wild type strain Sphingomonas sp. HXN-200 (0.049 U/g cdw). 
Thus, we can conclude that the recombinant E. coli overexpressing SpL is a 
highly active and easily available biocatalyst for aminolysis of esters. 
3.3.3 Effect of water content 
Water is generally not considered an ideal solvent for lipase catalyzed ester 
aminolysis reactions since water, in principle, will lead to the undesirable 
hydrolysis of the acyl donors and thus results in a significant loss in the amide 
yield. Hence, lipase catalyzed aminolysis of esters is normally carried out in 
anhydrous organic solvent, sometimes even with strict pretreatment of the 
solvent, substrates and enzymes by activated molecular sieves to keep absolute 
water free conditions. 
Candida antarctica lipase B (CALB), by far the most widely used enzyme for 
aminolysis of esters, is such an enzyme which prefers totally anhydrous 
organic solvent as the reaction media. As shown in Figure 3.7, even with trace 
amount of water present (0.5% on v/v basis), the performance of CALB drops 
a lot as compared with the anhydrous condition. Further increase of the water 
content results in a rapid decrease in the specific activity and final amide yield, 






Figure 3.7 Effect of water content on aminolysis of 10 mM methyl hexanoate 
with 20 mM benzylamine catalyzed by 10 mg of free CALB in 5 ml of n-
hexane. The water content is on a v/v basis. For the 0% case, 200 mg of 
activated 4A molsieve was added to ensure totally anhydrous condition. 
Specific activity was calculated after 30 min. Final amide yield was 
determined after 20 h. □: Specific activity (U/g protein); ■: Final amide yield 
(%). 
 
There are few examples of lipase catalyzed ester aminolysis in presence of 
water. The only two successful cases both involve using strong α nucleophiles 
such as hydroxylamine or hydrazine as acyl acceptors. No successful case has 
ever been reported in the literature for the lipase catalyzed efficient acylation 
of aliphatic or aromatic amines in presence of water. 
SpL is a quite unique enzyme which needs water for showing a catalytic 
activity for amide bond formation. As shown in Figure 3.6 c, interestingly, a 
trace amount of water is even a prerequisite for SpL to show its catalytic 
activity. SpL shows no catalytic activity in anhydrous n-hexane. With trace 
amount of water (0.5% on v/v basis) present, activity was observed. In the low 
water content region, the increase of water activity increases both the specific 












































amount of water in the reaction system for providing sufficient conformational 
flexibility of SpL, resulting in enzyme activation by unmasking and 
restructuring of the active site in a non-aqueous system. Further increasing the 
water concentration, results in a decrease of both the specific activity and final 
amide yield. This is possibly due to the competing hydrolysis reaction. 
The strict requirement of the use of dry catalyst powder in anhydrous organic 
solvent of the currently known lipases-catalyzed aminolysis of esters for 
amide synthesis significantly enhances the process cost and energy 
consumption. The superior ability of SpL to catalyze amide synthesis in 
presence of water (0.5-12 v/v %) with high activity and high yield allows for 
simple, practical and energy-saving syntheric process. 
3.3.4 Ester aminolysis catalyzed by SpL 
The substrate scope of SpL was investigated with a series of carbonic and 
heterocyclic esters and amines, as shown in Scheme 3.1 and Scheme 3.2. 
Only methyl esters were used in this study to ensure low E factors.23 For 
comparisons, parallel reactions were carried out with CALB or Novozyme 435 
as the catalyst. SpL, CALB and Novozyme 435 were used under their 
respective optimal conditions to enable fair comparisons. 
An E. coli strain overexpressing SpL with a 6×his-tag at the N-terminal was 
genetically engineered to facilitate the purification of SpL. Cells were 
cultivated and disrupted, and the CFE was subjected to affinity 
chromatography with a Ni-NTA column. His-tagged SpL was purified to 
apparent homogeneity as indicated on SDS-PAGE (Figure 3.6 b, Lane 5), 
with a molecular weight of 36 kDa. This value is very close to the predicted 




As shown in Scheme 3.1, SpL showed excellent activities for the series of 
carbonic esters examined. For the aminolysis of 1a-1d with 2a, SpL showed 
high activities ranging from 26.7 U/g to 115.9 U/g. These activities are much 
higher than those of CALB’s, which only range from 0.35 U/g to 21.5 U/g. It 
is worthwhile to note that for the aminolysis of relatively bulky ester 1a and 
1b, SpL is 45.3-76.3 times more active than CALB. This value is much higher 
than the 3.4 times value observed for the less bulky ester 1c. Apparently, with 
respect to acceptance for bulky esters, SpL is a superior enzyme to CALB. 
Scheme 3.1 Enzymatic synthesis of 3a-3g via aminolysis of 1a-1d with 2a-2d 
by free SpL or free CALB a 
 
 
 a The reaction was performed with 10 mM of ester and 20 mM of amine in 5 
ml n-hexane with 10 mg of free enzymes. For SpL, the reaction was carried 
out in partially hydrated n-hexane (4% on v/v basis); for CALB, 200 mg 
activated 4A molsieve was added to ensure a totally anhydrous environment. b 
Specific activity (U/g enzyme) was determined after 30 min. c Yield (%) to the 
amide was determined after 20 h. 
 
SpL also showed excellent activities for the series of carbonic amines 
examined and the activities are 16.4-155.5 times higher than those of CALB. 
As shown in Scheme 3.1, for the aminolysis of 1d with 2b-2d, SpL showed 
high activities ranging from 45.1 U/g to 108.2 U/g and a high amide yield 
ranging from 84.6% to 86.2%. It is interesting to note that even for the weak 
nucleophile 2b, SpL showed a high activity of 45.1 U/g and a very good amide 
yield of 84.6%. Compared with CALB, SpL is 155.5 times more active in this 




pharmaceutical important anilide derivatives, which cannot be efficiently 
synthesized by using the currently available enzyme collections. 
SpL’s superior ability for accepting aromatic amines is further supported by 
utilizing a series of heterocyclic aromatic amines as nucleophiles. As shown in 
Table 3.6, SpL showed high activities for accepting 2 aminopyrazoles and 1 
aminoisoxazole while Novozyme 435 shows a low or even no activity for 
these 3 heterocyclic aromatic amines investigated. 
It is worthwhile to note that heterocycle moieties like pyrazole and isoxazole 
are abundant in a wide range of drug molecules.193 The superior ability of SpL 
for accepting these series of pharmaceutically important amines offers the 
possibility of applying it for potential drug molecule synthesis in the future. 
Except for heterocyclic aromatic amines, SpL can even accept a series of 
secondary amines which possess significant steric hindrance near the amino 
group. As shown in Table 3.6, SpL showed much higher activities for 
acylation of 2i than Novozyme 435. This superiority offers possibility of 
applying SpL for efficient synthesis of amides containing secondary amine 
moieties, which remains to be one of the most challenging fields in enzyme 

















Table 3.6 Enzymatic synthesis of heterocyclic amides via aminolysis of esters 
1e-1f with amines 2e-2i by free SpL or Novozyme 435 a 
 
Entry Enzyme Ester Amine Product Time (h) Activity (U/g enzyme) b Yield (%) c 
1 SpL 1e 2e 3h 0.5 25.9 15.5 
2 SpL 1e 2f 3i 0.5 32.6 19.6 
3 SpL 1e 2g 3j 0.5 3.5 2.1 
4 SpL 1e 2h 3k 0.5 21.5 12.9 
5 SpL 1f 2e 3l 0.5 55.4 33.2 
6 SpL 1f 2f 3m 0.5 53.4 32.0 
7 SpL 1f 2g 3n 0.5 8.4 5.0 
8 SpL 1f 2h 3o 20 10.6 6.4 
9 SpL 1e 2i 3p 0.5 16.6 9.9 
10 Nov 435 1e 2e 3h 20 0 0 
11 Nov 435 1e 2f 3i 20 0 0 
12 Nov 435 1e 2g 3j 20 0 0 
13 Nov 435 1e 2h 3k 20 0.6 6.5 
14 Nov 435 1f 2e 3l 20 1.8 33.9 
15 Nov 435 1f 2f 3m 20 0 0 
16 Nov 435 1f 2g 3n 20 0 0 
17 Nov 435 1f 2h 3o 20 3.0 13.3 
18 Nov 435 1e 2i 3p 20 1.2 5.9 
 
a The reaction was performed with 10 mM of ester and 20 mM of amine in 5 
ml n-hexane with 10 mg of free SpL or 10 mg of Novozyme 435 at 30 oC. 
For SpL, the reaction was carried out in partially hydrated n-hexane (4% on 
v/v basis); For Novozyme 435, 200 mg activated 4A molsieve was added to 
ensure a totally anhydrous environment. b Specific activity was determined 
after 30 min. c Yield (%) to the amide was determined after the time stated 



























Scheme 3.2 Enzymatic synthesis of heterocyclic amides via aminolysis of 

























































































































































3.3.5 Enantioselectivity of SpL 
Lipase catalyzed enantioselective aminolysis of esters is a useful reaction to 
prepare enantiopure amides, which serve as a group of important physiological 
active compounds in the pharmaceutical manufacturing. However, till now, 
lipases are exclusively used for the resolution of chiral esters as well as amines, 
where relatively simple amines or esters are used. The application of lipases 
for enantioselective aminolysis towards the synthesis of highly 
enantiomerically enriched amides is rarely reported. 
Scheme 3.3 Synthesis of enantiopure amides 3q-3s via aminolysis of 1g with 





































Table 3.7 Enantioselective aminolysis of 1g with 2a and enantioselective 
acylation of 2j and 2k with 1d catalyzed by free SpL or free CALB a 
 




c Yield (%) c E e 
1 SpL 1g 2a (R)-3q 2 16.2 99.1 19.3 279.1 
2 SpL 1d 2j (R)-3r 1.5 43 94.3 31.7 52.0 
3 SpL 1d 2k (R)-3s 1 51.5 94.1 34.6 54.0 
4 CALB 1g 2a (R)-3q 1 14.2 43.8 9.3 2.7 
5 CALB 1d 2j (R)-3r 20 0.17 d 85.3 2 12.8 
6 CALB 1d 2k (R)-3s 20 0.48 d 95.5 5.7 46.5 
 
a The reaction was performed with 10 mM of ester and 20 mM of amine in 5 
ml n-hexane with 10 mg of pure enzymes. For SpL, the reaction was carried 
out in partially hydrated n-hexane (4% on v/v basis); for CALB, 200 mg 
activated molsieve 4A was added in order to ensure totally anhydrous 
environment. b Specific activity (U/g enzyme) was determined after 30 min. c 
eep (%) and yield (%) to amide was determined after the time stated in the 
table. d Specific activity was determined after 20 h. e E was calculated 




SpL is a highly enantioselective enzyme for ester aminolysis, which is 
potentially useful for preparation of pharmaceutically important enantiopure 
amide compounds. As shown in Table 3.7, SpL is a much more active and 
enantioselective enzyme than CALB for the 1 racemic ester and 2 racemic 
amines studied. An enantiomeric ratio (E) of 279.1 is achieved for SpL 
catalyzed aminolysis of racemic 1g with 2a to give (R)-3q in 99.1% ee, which 
is much higher than that of CALB (2.7 for 1g). Interestingly, the R and S 
enantiomer of 3q shows different anticonvulsant activity towards mice and its 
R enantiomer is principally responsible for the anticonvulsant activity and 
provides full protection in mice against MES-induced seizures at doses below 
100 mg/kg.194 SpL also showed better enantioselectivity than CALB towards 
the enantioselective acylation of racemic amines 2j and 2k with 1d, showing E 
of 52.0 and 54.0, to give (R)-3r and (R)-3s in 94.3% and 94.1% ee and in 
good amide yield of 31.7% and 34.6%. 
3.3.6 Synthesis of amides in high concentration with wet cells of E. coli 
(SpL) 
The high cost of lipase preparations (free or immobilized enzymes) strongly 
limits their large scale industrial application. Whole cell biocatalyst, which 
involves no cell lysis and enzyme purification, provides a readily available and 
low-cost catalyst, which can be potentially applied in the large scale industrial 
syntheses. The currently commercially available lipase preparations are 
exclusively free or immobilized enzymes and no whole cell system has ever 
been developed. Thus, the potential of E. coli (SpL) cells as active whole cell 




yield was acquired at high substrate concentrations (50 mM-120 mM) and in 
short reaction time. 
Firstly, E. coli (SpL) catalyzed aminolysis of methyl hexanoate with 
benzylamine was chosen as a model reaction and the water content was 
optimized to quantify the optimal water concentration for E. coli (SpL) 
catalyzed ester aminolysis in n-hexane. As shown in Figure 3.6 d, the optimal 
water content is 16% for achieving the highest amide yield and maintaining a 
high activity for E. coli (SpL). 
Considering the fact that lyophilisation is a highly energy-intensive process 
and E. coli (SpL) needs 16% of water to show the best performance, using wet 
cells directly is highly desirable since it lowers the cost to the minimum. The 
water content of the reaction system is easily controlled to be 16% (v/v) by 
controlling the catalyst loading. Based on the measured 86.3% water content 
of the wet cell pellet and the 16% (v/v) optimal water content for E. coli (SpL), 
926.7 mg of wet cell pellet of E. coli (SpL) in 5 ml n-hexane is calculated to 
give the optimal water activity. Mixing via a magnetic stirrer, instead of a 
shaking flask is used to ensure good dispersion of the wet cell pellet and 
efficient mixing of the reaction mixture. 
Table 3.8 Synthesis of amides in high concentration with wet cells of E. coli 
(SpL) a 
 
Entry Ester Amine Amide Ester conc. (mM) Amine conc. (mM) Time (h) Activity (U/g cdw) b Yield (%) c eep (%) 
c E d 
1 1a 2a 3a 120 120 2 114.3 80.7 - - 
2 1b 2a 3b 80 90 0.5 105.4 >99 - - 
3 1c 2a 3c 100 120 0.5 132.3 >99 - - 
4 1d 2a 3d 80 90 2 81.9 79.9 - - 
5 1d 2b 3e 100 120 7 34.5 71.5 - - 
6 1d 2c 3f 120 120 2 129.7 85.9 - - 
7 1d 2d 3g 50 60 3 16.4 59.1 - - 
8 1g 2a (R)-3q 50 60 1 7.3 23.2 97.9 123 
9 4a 2a 3d 80 90 1 99.8 >99 - - 
 
a The reaction was performed in 5 ml n-hexane with 926.7 mg wet cell of E. 




activity (U/g cdw) was determined after 30 min. c Amide yield (%) and eep (%) 
were determined after the time stated in the table. d E was calculated according 
to the equation E=ln [1-y (1+eep)]/ln [1-y (1-eep)], y is the yield. 
 
Under the optimized reaction conditions, wet cells of E. coli (SpL) serve as a 
highly active and enantioselective catalyst for amide synthesis at high 
substrate concentrations, as shown in Table 3.8. Except for aminolysis of 1d 
with 2b, the reaction generally finished within 3 h to give good to quantative 
amide yield. It is noticeable that for the aminolysis of 1b and 1c with 2a, the 
reaction finished within just 0.5 h to give an amide yield of more than 99% 
and with high amide concentrations of more than 80 mM and 100 mM 
respectively. For the aminolysis of 1a with 2a and 1d with 2c, no obvious 
inhibition effect was observed for E. coli (SpL) cells with substrate 
concentration as high as 120 mM and amide yields of 80.7% and 85.9% can be 
achieved in 2 h. E. coli (SpL) (114.3 U/g) is 90.7 times more active than 
Novozyme 435 (1.26 U/g) for aminolysis of 1a with 2a. The potential use of 
wet cells of E. coli (SpL) for the synthesis of 3a, a novel tyrosinase inhibitor 
and 5-HT3 receptor agonist is possible.
195, 196 It is also interesting to note that 
for acylation of 1d with 2b, a good amide yield of 71.5% (71.5 mM of 3e) was 
achieved after 7 h at 30 °C, which is much better than the 55% yield (55 mM 
of 3e) achieved by using Novozyme 435 and 25% yield (25 mM of 3e) 
achieved by using Pseudomonas stutzeri lipase (PSL) after 20 h at 50 °C.96 
This superior ability of E. coli (SpL) cells to accept 2b as a nucleophile at high 
substrate concentration offers its specific application in the synthesis of 
pharmaceutically important anilide derivatives in the industry. 
Wet cell of E. coli (SpL) is also an excellent catalyst for amide synthesis via 




condensation of 4a with 2a finished within just 1 h to give an amide yield of 
more than 99%.  
For enantioselectivity, at high substrate concentration, a high enantiomeric 
ratio of 123 can be maintained for wet cells of E. coli (SpL)-catalyzed 
aminolysis of 1g with 2a and the amide ee can be kept as high as 97.9% with a 
yield of 23.2%. 
3.3.7 Mechanism of SpL-catalyzed aminolysis of esters 
Since water is involved in SpL-catalyzed aminolysis of esters, it is interesting 
to study whether SpL catalyzes amide formation via a carboxylic acid 
intermediate. There are few studies about reaction mechanisms of lipase-
catalyzed ester aminolysis in presence of water. The representative two 
mechanism study examples are lipase catalyzed ester hydroxylaminolysis 
reactions in partially hydrated organic solvent or in aqueous medium.52, 197 The 
hydroxamic acid formed was proposed to come from either direct ester 
hydroxylaminolysis or amidation of the carboxylic acid released by ester 
hydrolysis with hydroxylamine, since carboxylic acid was detected during the 
reaction course, which was subsequently converted to hydroxamic acid by 
reacting with hydroxylamine.52, 197 However, which pathway is dominating for 




Figure 3.8 a) Possible mechanisms of SpL-catalyzed aminolysis of 1d with 2a. 
3d might be produced by direct ester aminolysis without forming the 
carboxylic acid intermediate. 3d might also be produced by condensation of 
the carboxylic acid produced by ester hydrolysis with amine. b) Time course 
of free SpL-catalyzed aminolysis of 1d with 2a in partially hydrated n-hexane 
(4% on v/v basis) with 1 mg free SpL. c) Time course of free SpL-catalyzed 
hydrolysis of 1d in partially hydrated n-hexane (4% on v/v basis) with 1 mg 
free SpL. d) Time course of free SpL-catalyzed condensation of 4a and 2a in 
partially hydrated n-hexane (4% on v/v basis) with 1 mg free SpL. ■: 3d; ▲: 
4a; ♦: 1d. 
 
Aminolysis of 1d with 2a was set as the model reaction for determining the 
detailed reaction mechanism involved in SpL catalyzed aminolysis of esters in 
presence of water. The concentration of 1d, 3d and 4a was monitored as the 
reaction progressed. As shown in Figure 3.8 b, in the first 30 min, 4a 
concentration was accumulated up to 0.91 mM, indicating there was indeed 
some ester hydrolysis occurring. It is interesting to note that after 30 min, the 
carboxylic acid produced can be further converted to amide, with 
concentration gradually reduced from 0.91 mM to 0.34 mM, indicating 




Whether pathway II is the main pathway for amide formation was determined 
by measuring the relative initial reaction rate of 3 reactions: ester aminolysis, 
carboxylic acid and amine condensation and ester hydrolysis. As shown in 
Figure 3.8 c and d, ester hydrolysis is the rate limiting step in pathway II, 
illustrating that the total reaction rate of pathway II cannot exceed 84.1 μmol/ 
(min·g). This value is 10 times lower than the measured total reaction rate for 
aminolysis of 1d with 2a (849.1 μmol/ (min·g)), demonstrating that pathway I 
is the major pathway responsible for amide formation (responsible for 90% of 
the total amide formation). 
3.3.8 Carboxylic acid as the acyl donor 
The unique ability of SpL to catalyze direct condensation of carboxylic acid 
and amine to give amide is surprising since carboxylic acids are generally 
considered to be inefficient substrates for lipase-catalyzed aminolysis 
reactions due to the unreactive salts formed between carboxylic acids and 
amines.20 Only a few examples of using carboxylic acids directly for 
aminolysis reactions have been reported. Unfortunately, most of them require 
long reaction time, high enzyme loading or high temperature for the 
condensation to progress and the yield of the target amide is poor to 
moderate.97, 198, 199, 200, 201, 202, 203 Although hydroxylamine and hydrazine, as 
well as their derivatives, can be acylated by carboxylic acid in presence of a 
series of lipases and esterases with essentially quantitative conversions,51, 52, 197 
direct carboxylic acid amidation by aliphatic amine is still quite challenging. 
SpL’s superior ability for direct carboxylic acid amidation is clearly shown in 
Figure 3.8 d. The reaction finished in 1 h to give 9.9 mM 3d as the product. 




the substrate. Considering the fact that a similar amide yield was achieved for 
carboxylic acid as compared with the methyl ester (both achieve more than 99% 
yield), carboxylic acid is a more suitable substrate for SpL in this case. In 
contrast, CALB can hardly accept carboxylic acids as the substrates. A 45 
times slower initial reaction rate and a 27 times lower amide yield were 
observed for the CALB-catalyzed condensation of 4a with 2a as compared 
with aminolysis of 1d. This unique character of SpL to catalyze amide 
formation via condensation of carboxylic acids and amines offers a more 
economically viable, more environmentally sustainable and simpler 
methodology for amide synthesis than using esters as acyl donors. 
3.4 Conclusions 
Sphingomonas sp. HXN-200, Rhodococcus sp. MHD 246, Rhodococcus sp. 
MHD 280 and Bacillus sp. ATOL-1 were identified as active whole cell 
biocatalysts for aminolysis of methyl hexanoate with n-pentylamine by 
screening of olive oil, methyl hexanoate, octane and toluene degrading strains 
isolated in our lab. A unique lipase (SpL) from Sphingomonas sp. HXN-200 
was cloned based on the prediction using whole genomic information of this 
strain and efficiently expressed in Escherichia coli as a powerful biocatalyst 
for amide synthesis via aminolysis of esters. SpL shows a broad substrate 
scope, highly active for a series of carbonic and heterocyclic esters and amines. 
It is especially exciting to note SpL’s superior ability for accepting a series of 
heterocyclic aromatic amines and secondary amines, since these series of 
amines cannot be efficiently acylated with the present existing enzyme 
collections such as CALB. SpL demonstrated also much better 




Different from CALB, SpL is an intracellular enzyme and shows good 
catalytic activity in presence of water. Particularly, SpL is a highly active 
enzyme for accepting carboxylic acid instead of ester as the aminolysis 
substrate, which is generally considered infeasible by using the present 
existing enzyme collections. E. coli (SpL) wet cell is utilized as the first 
efficient whole cell biocatalyst for amide synthesis via ester aminolysis at high 
substrate concentrations. Synthesis of amides in high concentration (up to 103 
mM) was achieved with wet cells of E. coli (SpL) in high yield and short 
reaction time. The easily available, active and enantioselective E. coli (SpL) 















Chapter 4. X-ray structure of SpL, structure-based 
catalytic insights, and bacterial HSL-like lipases as new 
source of enzymes for efficient amide synthesis via 
aminolysis of esters 
4.1 Introduction 
Determining the three-dimensional structures of proteins is crucial for 
understanding the functions of proteins at molecular level.135 In enzymology, 
3D structures of enzymes offer insights into the detailed catalytic mechanisms 
and are thus important for elucidating basic theoretical issues. 
Techniques including X-ray crystallography, NMR spectroscopy and electron 
microscopy are developed for determining the structures of proteins.137, 138, 139, 
140, 141, 142 Due to the limitations of NMR spectroscopy for determining large 
protein structures and the unsatisfactory resolution of electron microscopy, X-
ray crystallography is still the most widely used method for protein structure 
determination.143, 144, 145 
SpL was proved to be a powerful enzyme for amide synthesis in the previous 
chapter (Chapter 3). Thus we were interested to crystallize SpL and solve its 
structure to elucidate its structure and function relationship. Moreover, we 
were also interested to study the relationship of SpL to other aminolyases. In 
other words, we wanted to know whether enzymes with significant structural 







4.2 Experimental section 
4.2.1 Strains, plasmids and chemicals 
All the chemicals were obtained from commercial suppliers and used without 
further purification: sodium cacodylate trihydrate (≥98%, Sigma Aldrich), 
polyethylene glycol 8000 (Sigma Aldrich), sodium acetate anhydrous (>99%, 
Sigma Aldrich), n-hexane (HPLC grade, TEDIA), methanol (99.8%, Sigma 
Aldrich), acetonitrile (HPLC grade, TEDIA), 1-phenylethanol (98%, Sigma 
Aldrich) and trifluoroacetic acid (99%, Sigma Aldrich). 
Escherichia coli T7 expression strain, enterokinase (light chain), restriction 
enzymes (BamHI and XhoI) and T4 DNA quick ligase were purchased from 
New England Biolabs. Expression vector pRSFDuet-1 was acquired from 
Novagen. Oligos (primers), IPTG (inducer, >99%), agarose (molecular 
biology grade), Tris-HCl buffer (1 M, pH 8.0), Tris-HCl buffer (1 M, pH 7.5) 
and 10×TAE buffer (ultrapure grade) were purchased from 1st BASE, 
Singapore. Monopotassium phosphate (≥99.0%), dipotassium phosphate 
(≥98%), sodium phosphate dibasic heptahydrate (≥99.99%), sodium phosphate 
monobasic monohydrate (≥98%), sodium chloride (≥99.5%), calcium chloride 
dihydrate (≥99.0%), imidazole (≥99%), kanamycin (>99%), glycerol (≥99%) 
and Bradford reagent were purchased from Sigma Aldrich. Phusion DNA 
polymerase, plasmid miniprep kit, gel extraction kit and PCR purification kit 
were purchased from Thermo Scientific. LB broth, LB agar, tryptone and 
yeast extract were purchased from Biomed Diagnostics. 4%–12% NuPAGE® 
Bis-Tris precast gels (in MES-SDS Running Buffer) were acquired from life 




4.2.2 Engineering of a SpL variant containing an enterokinase recognition 
site 
To facilitate the purification of detagged SpL, the following primers were used 
for inserting an enterokinase recognition site: 
Forward Primer: ACT GGG ATC CGG ACG ATG ATG ACA AGA TGA 
CCG ACA GCA CGA CCC ATT ACA 
(BamHI restriction site is marked by an underline. The sequence encoding the 
enterokinase recognition site is marked in red) 
Reverse primer: ACT GCT CGA GTC ATG CCG CTC CGG TAG CCT CGG 
CG 
(XhoI restriction site is marked by an underline) 
PCRs were carried out using a Biorad MycyclerTM thermo cycler. 
The plasmid pRSFDuet-SpL was used as the PCR template. The following 
PCR program was used for amplification: initial denaturation at 94 °C for 5 
min, denaturation at 94 °C for 30 s, annealing at 72 °C for 30 s, extension at 
72 °C for 45 s, total 33 cycles, final extension at 72 °C for 10 min. 
PCR product was purified on 1% agarose gel in TAE buffer and then 
subjected to double digestion with BamHI and XhoI followed by ligation to 
pRSFDuet-1 vector. The ligation product was then transformed into 
Escherichia coli T7 express competent cells and the positive transformant was 
selected on LB agar plate with 50 μg/ml of kanamycin present. DNA 
sequencing confirmed the successful construction of the recombinant E.coli 






4.2.3 Cell growth and protein expression 
E. coli (his-tagged SpL), E.coli (SpL for which the his-tag which can be cut 
off with enterokinase) or E.coli (his-tagged Sto-Est) was firstly grown in LB 
medium containing kanamycin (50 μg/ml) at 37 °C for 4-6 h and then 
inoculated into TB (Terrific Broth) medium containing kanamycin (50 μg/ml). 
When OD600 reached 0.6-0.8, 0.25 mM of Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to induce the protein expression. The 
cells were let to continue growing for 14−16 h at 22 °C and the cells were then 
harvested by centrifugation (5000 g, 5 min), washed with deionized water 
once and resuspended in KP buffer (10 mM, pH 8.0) for protein purification. 
4.2.4 Purification of his-tagged SpL, detagged SpL and his-tagged Sto-Est 
The cell suspension was let pass through a homogenizer twice, followed by 
centrifugation (23000 g, 4 oC, and 50 min) to remove the cell debris. The cell 
free extract was then filtered with a 0.2 µm Supor® membrane to remove small 
particles present and subjected to FPLC for protein purification. 
Firstly, affinity chromatography was performed on an AKTA purifier with a 
Ni-NTA column to remove most of the impurities. To monitor the purification 
process, the total protein present in the solution was monitored by setting the 
detector wavelength at 280 nm. The temperature was kept at 4 oC for the 
whole process. 
The cell free extract was loaded onto the Ni-NTA column manually. Impure 
proteins were then washed out by using a wash buffer (20 mM sodium 
phosphate, 500 mM NaCl, pH 7.4) with 30 mM imidazole present. After all of 
the impure proteins have been removed (indicated by a stabilized 280 nm 




pH 7.4) with 300 mM of imidazole present was used to wash out the target 
protein. The salts and imidazole present in the enzyme solution were removed 
by washing the protein solution with deionized water in an Amicon Ultra-15 
Centrifugal Filter Units (20 kD). For his-tagged Sto-Est, the purification 
finishes after this step and the protein concentration was adjusted to 5 mg/ml 
for activity test. 
For his-tagged SpL, size exclusion chromatography was performed next on a 
Superdex 200 10/300 GL column with a mobile phase consisting of 20 mM 
Tris-HCl buffer (pH 7.5) and 20 mM NaCl at a flow rate of 0.5 ml/min. After 
this step of purification, the buffer for dissolving the protein was changed to 
ultrapure water and the protein concentration was measured by Bradford assay 
and protein purity was checked by SDS-PAGE. The protein sample was 
subjected to crystallization without further handling. 
For detagged SpL, after the affinity chromatography, the buffer for dissolving 
the protein was changed to enterokinase cutting buffer (20 mM Tris-HCl (pH 
8.0), 50 mM NaCl, 2 mM CaCl2) and then 0.32 μg enterokinase was added to 
cut the his-tag off at 23 oC for 1 week. The protein was then let pass through 
the his-trap column again to remove the cutted off his-tag and SpL which still 
keeps the his-tag. Size exclusion chromatography with the same conditions for 
purifying his-tagged SpL was used at last to refine the protein.  
4.2.5 Intact mass measurement of his-tagged SpL and detagged SpL 
Sample preparation: 
Buffer for dissolving the protein was exchanged into 1% formic acid in water. 
This was performed by adding 1 ul of each protein sample into 22 ul of 0.1% 




spin column pre-equilibrated with 0.1% formic acid in water. The columns 
were centrifuged at 1000 g for 1 min at room temperature. The flow-through 
was collected and diluted 1:1 (v/v) with acetonitrile/water/formic acid 
0.495:0.495:0.01 (v/v). 
Mass spectrometry:  
The samples were analyzed by static nanospray ionisation interfaced to a Qtof 
mass spectrometer. Data was acquired over the mass range 250-6000 Th at a 
scan rate of 2.5 sec/scan and a minimum of 50 scans were collected and 
combined to provide an adequate S: N ratio. 
Data analysis: 
Average masses were calculated from the charge state distribution of the 
observed spectra using the following formulae: 
The mass-to-charge ratio (m/z) of an ion can be defined as follows, where M 
is the average molecular mass of the protein and H is the mass of a proton 
(1.007941Da): 
m/z=(M+zH)/z    equation (1) 
Where m is the mass of the ion and z is the number of charges present on that 
ion. Rearranging form: 
m=M+zH    equation (2) 
m-zH=M    equation (3) 
M=z(m/z-H)    equation (4) 
z can be estimated from two adjacent m/z values; m1/z1 and m2/z2; where 
z1=z2+1: 




The average molecular mass of the protein was calculated from equation (4) 
for each m/z value observed. 
4.2.6 Crystallization of SpL 
Both his-tagged SpL and detagged SpL were concentrated to 50 mg/ml for 
crystallization screening experiment. The initial screening was performed with 
three sparse matrixes (Classics, Morpheus and Pegs II) by sitting-drop vapor 
diffusion technique in CombiClover plates.204, 205 The crystals were let to grow 
at 25 oC for 2 weeks and then visualized with microscope to find the optimal 
conditions for protein crystallization. 
4.2.7 Structure determination of SpL 
The crystals acquired from initial screening were used directly for structure 
resolution without further optimization. One crystal was cryoprotected by 
supplementation with 15% glycerol and immediately frozen in liquid nitrogen 
at -196 oC. Data from the flash-cooled crystal was collected at the beam line 
I04-1 at Diamond Light Source. 
The crystal was fixed on a cryoloop (Hampton Research, Aliso Viejo, CA, 
USA) for X-ray diffraction analysis. The temperature was kept at 100 K under 
a nitrogen stream and X-ray’s wavelength was set to be 1.0 Å for creating the 
diffraction pattern. A DIP-6040 image plate detector (Bruker-AXS, Madison, 
WI, USA) was used for collecting the diffraction data. DENZO and 
SCALEPACK programs as standalones or in the HKL2000 suite were used for 
data processing.206 
Molrep in the CCP4 crystallographic suite was used for structure resolution of 
SpL by setting a monomer of the crystal structure of Sto-Est (3AIO.pdb) as 




cycles using REFMAC and COOT.209, 210 RAMPAGE was used to evaluate 
the effect of structural reﬁnement by the free R-factor and stereochemical 
parameters.211 All of the protein structures were visualized by PYMOL 
(http://pymol.org). 
The tunnel-like active site of SpL was identiﬁed by using the program 
CAVER.212 The interface between the monomers of SpL was analyzed by 
using PISA and PIC.213, 214 
4.2.8 Cocrystallization of SpL with 3-amino-5-methylisoxazole 2g and 
dimethylarsinic acid 
SpL’s structure with an arsenic adduct was acquired by crystallizing SpL in 
the following conditions: 0.1 M sodium cacodylate buffer at pH 6.5 with 30% 
PEG 8000 as the precipitant and 0.1 M sodium acetate as the salt. 
The enzyme-amine complex crystal was acquired by firstly incubating the 
proteins of SpL (50 mg/ml) with 100 mM 3-amino-5-methylisoxazole 2g at 0 
oC for 30 min prior to cocrystallization. The cocrystallization was performed 
under the same condition as crystallization of SpL, consisting of 0.1 M sodium 
cacodylate buffer at pH 6.5 with 30% PEG 8000 as the precipitant and 0.2 M 
sodium acetate as the salt. Before data collection, crystals were cryoprotected 
by supplemented with 15% glycerol and then quickly frozen with liquid 
nitrogen. The structures of SpL complexed with dimethylarsinic acid and 3-
amino-5-methylisoxazole 2g were solved by molecular replacement using the 







4.2.9 Engineering of recombinant E.coli overexpressing his-tagged Sto-Est 
The gene of Sto-Est was synthesized and cloned into pUC18 by Genescript, 
Singapore. This plasmid was used as the template for PCR and the following 
primers were used to amplify the Sto-Est gene: 
Forward Primer: ACT GGG ATC CGA TGA TAG ACC CTA AAA TTA 
AAA AAT T 
(BamHI restriction site is marked by an underline) 
Reverse Primer: ACT GCT CGA GTT ATT TTC CGT AAA ATA CTT TTC 
TTA 
(Xho I restriction site is marked by an underline) 
The following PCR program was used for amplifying Sto-Est: initial 
denaturation at 94 °C for 5 min, denaturation at 94 °C for 30 s, annealing at 
60.8 °C for 30 s, extension at 72 °C for 45 s, total 33 cycles, final extension at 
72 °C for 10 min. 
PCR product was purified on 1% agarose gel in TAE buffer and then 
subjected to double digestion with BamHI and XhoI followed by ligation to 
pRSFDuet-1 vector. The ligation product was then transformed into 
Escherichia coli T7 express competent cells and the positive transformant was 
selected on LB agar plate with 50 μg/ml of kanamycin present. DNA 
sequencing confirmed the successful construction of the recombinant E.coli 
overexpressing his-tagged Sto-Est. 
4.3 Results and discussion 
4.3.1 Purification of his-tagged SpL and detagged SpL 
Acquiring the target protein in high purity and large amount is normally the 




crystallization in certain cases, both his-tagged SpL and detagged SpL were 
purified to apparent purity for protein crystallization screening experiment, as 
shown in Figure 4.1. 
It is worthwhile to note that detagged SpL’s apparent molecular weight is 
smaller than that of his-tagged SpL, demonstrating that his-tag was 
successfully removed in detagged SpL. 
 
Figure 4.1 SDS-PAGE of purified his-tagged SpL and detagged SpL. Lane 1: 
Marker; Lane 2: his-tagged SpL; Lane 3: detagged SpL 
 
4.3.2 Intact mass measurement of his-tagged SpL and detagged SpL 
In order to further confirm the fidelity of the purified his-tagged SpL and 
detagged SpL, MALDI-TOF MS was utilized to analyze the protein molecular 
weight. The full sequences and calculated molecular weights of his-tagged 












Number of residues: 329 










Number of residues: 315 
Calculated average mass [Da]: 33834.5154 
For his-tagged SpL, the protein molecular weight was determined to be 
35314.84 Da by calculating using the two adjacent m/z values, as shown in 
Figure 4.2. The deviation of 132.34 Da to the calculated molecular weight of 
35447.1830 Da is assumed to be due to the N-terminal des-Met modification 
after expression. 
For detagged SpL, the measured molecular weight is 33833.12, which is 





Figure 4.2 Mass spectroscopy of 6×his-tagged SpL 
 
Measured mass for 6×his-tagged SpL: 
m/z: 803.65 charge: 44 + MW [Da]: 35316.25 Error [Da]: 1.41 
m/z: 822.28 charge: 43 + MW [Da]: 35314.70 Error [Da]: ‐0.14 
m/z: 841.83 charge: 42 + MW [Da]: 35314.53 Error [Da]: ‐0.31 
m/z: 862.34 charge: 41 + MW [Da]: 35314.61 Error [Da]: ‐0.22 
m/z: 883.89 charge: 40 + MW [Da]: 35315.28 Error [Da]: 0.44 
m/z: 906.5 charge: 39 + MW [Da]: 35314.19 Error [Da]: ‐0.65 
m/z: 930.34 charge: 38 + MW [Da]: 35314.62 Error [Da]: ‐0.22 
m/z: 955.46 charge: 37 + MW [Da]: 35314.73 Error [Da]: ‐0.11 
m/z: 981.97 charge: 36 + MW [Da]: 35314.63 Error [Da]: ‐0.20 
Deconvoluted MW [Da]: 35314.84  
Standard deviation [Da]: 0.60 






Figure 4.3 Mass spectroscopy of detagged SpL 
 
Measured mass for detagged SpL: 
m/z: 806.59 charge: 42 + MW [Da]: 33834.45 Error [Da]: 1.33 
m/z: 826.19 charge: 41 + MW [Da]: 33832.46 Error [Da]: ‐0.65 
m/z: 846.81 charge: 40 + MW [Da]: 33832.08 Error [Da]: ‐1.04 
m/z: 868.52 charge: 39 + MW [Da]: 33832.97 Error [Da]: ‐0.15 
m/z: 891.35 charge: 38 + MW [Da]: 33833.00 Error [Da]: ‐0.12 
m/z: 915.41 charge: 37 + MW [Da]: 33832.88 Error [Da]: ‐0.24 
m/z: 940.82 charge: 36 + MW [Da]: 33833.23 Error [Da]: 0.11 
m/z: 967.69 charge: 35 + MW [Da]: 33833.87 Error [Da]: 0.75 
m/z: 996.1 charge: 34 + MW [Da]: 33833.13 Error [Da]: 0.01 
Deconvoluted MW [Da]: 33833.12  
Standard deviation [Da]: 0.70 
Calculated average mass [Da]: 33834.5154 




4.3.3 Crystallization of SpL  
Considering the fact that the position of his-tag will affect the process of 
crystallization significantly for some proteins, both his-tagged and detagged 
SpL were subjected to crystallization screening experiments.215 The initial 
screening was performed with three sparse matrixes (Classics, Morpheus and 
Pegs II) and high quality crystals were obtained from Classics screening for 
both his-tagged and detagged SpL. The optimized conditions for crystallizing 
SpL was 0.1 M sodium cacodylate buffer at pH 6.5 with 30% PEG 8000 as the 
precipitant and 0.2 M sodium acetate as the salt. 
 
Figure 4.4 Crystals of his-tagged SpL 
 
 








4.3.4 Structure of SpL 
One crystal of detagged SpL was subjected to X-ray diffraction analysis and 
good diffraction pattern was observed, as shown in Figure 4.6. Thus it was 
used for structure resolution. 
The full diffraction data was collected in house on detagged SpL and the 
structure was solved by molecular replacement of Sto-Est (3AIO.pdb). 
 
Figure 4.6 Diffraction pattern of detagged SpL collected in synchrotron 
 





Space group P21 
Asymmetric unit 2 molecules 









The overall structure of SpL is quite similar to that of Sto-Est (3AIO.pdb), as 




of SpL, which is a representing feature of the lipid splitting enzymes.45, 46 The 
active site of SpL consists of nucleophilic Ser159, acidic Asp251 and basic 
His281, which is quite conserved among the lipase and esterase family.216 
Ser159 was confirmed to be the nucleophilic centre since the mutation of 
Ser159 to Ala leads to the diminishing of the catalytic activity. It is interesting 
to note that the arrangement of the catalytic triad of SpL is quite similar to that 
of Sto-Est, as shown in Figure 4.7 b. 
However, different from Sto-Est, for which the amino acid residues 1–20 and 
the uncleaved N-terminal his-tag are not visible in the electron-density map 
due to the disorder in the crystal, the additional sequence present at the N-
terminal of SpL gives rise to a capping helix which partially covers one of the 
entrances to its active site.217 
 
 
Figure 4.7 a) The fully refined structure of SpL at 1.7 Å (blue) compared with 
that of Sto-Est (3AIO.pdb) (green); b) Catalytic triad of SpL (blue) and Sto-
Est (green). 
 
In most lipases, a mobile lid covers the substrate binding site.218 The role of 
this mobile structure in modulating lipase function is crucial. It not only 






also participates in the substrate binding, controlling the activity and 
selectivity.218, 219 
The role of this lid region in the catalytic performance of SpL was studied by 
creating two truncated SpL mutants without the cap (SpL (ΔH) and SpL 
(ΔHL)), as shown in Figure 4.8. Interestingly, both of these two truncated 
SpL mutants showed no catalytic activity for ester hydrolysis and aminolysis. 
This observation is consistent with the importance of the lid. 
 
Figure 4.8 N-terminal truncation of SpL to understand the role of the lid 
region in modulating its function. The lid region which is consists of an α 
helix and a loop is marked by a red color. SpL (ΔH) is the truncated SpL 
mutant without the α helix region (M T D S T T H Y T R P D V A A F L A F 
L N A Q E G). SpL (ΔHL) is the truncated SpL mutant without the α helix and 
loop region (M T D S T T H Y T R P D V A A F L A F L N A Q E G P 
K M E E M P P) 
 
Like for all the other HSL-like lipases, a dimer is found in the asymmetric unit 
of SpL and the maximum interface between monomers is 661 Å2. The 
inclination of the HSL-like lipases to form oligomers is widely known. For 
example, Sto-Est is a tetramer in the solution. Pyrobaculum calidifontis 
esterase (PestE) instead, forms a dimer. Existing study shows that the 






Figure 4.9 Dimer is found in the asymmetric unit of SpL 
 
The substrate binding pocket of SpL is a tunnel with two entrances, similar to 
that of Sto-Est. The nucleophilic serine sits at the bottom of this tunnel, where 
the acyl transferring reaction takes place. It is interesting to note that both of 
the two entrances have a cap-like region. Except for the N-terminal helix and 
loop which partially covers entrance 1 to its active site, as shown in Figure 
4.10 a, M214, which has two conformations, can open or close the access to 
catalytic serine from entrance 2, as shown in Figure 4.11. 
    
Figure 4.10 a) The tunnel like active site of SpL. The N-terminal helix which 
partially covers entrance 1 to its active site is marked in red; b) The tunnel like 
active site of Sto-Est. 









Figure 4.11 M214 has two conformations which can open or close the access 
to catalytic serine from entrance 2. This figure is the enlarged image from the 
region marked by a red frame in Figure 4.10 a.  
 
4.3.5 Complex of SpL with dimethylarsinic acid and 3-amino-5-
methylisoxazole 2g 
To fully map out the substrate binding site of SpL for ester and amine and 
explore the detailed catalytic mechanism of SpL-catalyzed aminolysis of ester, 
SpL was cocrystallized with dimethylarsinic acid and 3-amino-5-
methylisoxazole 2g. 
The structure of SpL-dimethylarsinic acid was solved to 1.7 Å resolution and 
is essentially identical to that of the noninhibited form, except that the active 
site Ser159 of each monomer has a dimethylarsinic acid adduct. 
The carbonyl oxygen atom of dimethylarsinic acid is located within the 
hydrogen bond distance (2.8-3.0 Å) from the main chain nitrogen atoms of 
G92, G93 and A160, indicating that these residues form the oxyanion hole, as 
shown in Figure 4.12. It is interesting to note that the two methyl side chains 
of dimethylarsinic acid are present in entrance 1 of the substrate binding 




entrance 1 and the corresponding half tunnel is responsible for ester 
recognition and binding. 
 
Figure 4.12 Structure of SpL which has a dimethylarsinic acid adduct 
The structure of SpL complexed with 3-amino-5-methylisoxazole was also 
solved to 1.7 Å resolution. As shown in Figure 4.13, each active site of SpL 
accommodates two 3-amino-5-methylisoxazole molecules. It is interesting to 
note that both of two molecules are present in left half tunnel of SpL, with the 
first one binded at the active site while the second one located at the entrance 
of the binding pocket. This suggests that the amine substrate most likely enters 
the active site via entrance 2 and the corresponding left half tunnel is 








Figure 4.13 Binding of 3-amino-5-methylisoxazole 2g in the active site of 
SpL (2 molecules in every active site) 
 
The recognition of ester and amine substrates from two different entrances 
simultaneously of SpL is quite exciting since in comparison with other known 
aminolysis enzyme such as CALB having a catalytic pocket with one entrance, 
SpL can have better orientation and less confliction of ester and amine 
substrates inside the binding pocket thus can accept both bulky esters and 
bulky amines simultaneously, giving rise to a broader substrate range for 
aminolysis. 
4.3.6 Comparison of SpL’s structure with that of CALB and CALA 
Candida antarctica lipase B (CALB) and lipase A (CALA) are the most 
widely used enzymes for amide bond formation till now.33, 86, 87 The crystal 
structures of CALB and CALA were resolved in 1994 and 2008 
respectively.220, 221 





Figure 4.14 Comparison of SpL’s overall structure with that of CALB. SpL’s 
structure is marked by a grey and red color while CALB’s structure is marked 
by a yellow color.  
 
CALB has a relatively exposed catalytic site. The nucleophilic serine is 
directly accessible by the external solvent through a narrow channel of 
approximately 10 Å × 4 Å wide and 12 Å deep.220 The channel walls are 
highly hydrophobic and consist mostly of aliphatic residues, like for all the 
other lipases.220 One representing feature of CALB is that the short helix α5 
consists of the lid region.220 Different from other lipases, this lid region is 
found to be always in an open form, which makes the active site always 
accessible.220 
SpL is quite different from CALB in the overall structure. As shown in Figure 
4.14, except for a similar spatial arrangement of the catalytic triad, the 
infrastructure of SpL and CALB has little similarity. SpL and CALB are also 
quite different in the accessibility of the catalytic site. As shown in Figure 






Figure 4.15 Comparison of SpL’s active site with that of CALB 
 
CALA goes to another extreme. Its discrete lid domain, which is composed of 
residues 217-308 between strands B7 and B8 in the α/β hydrolase domain 
totally shields its catalytic cavity from the bulk solvent.221 In other words, its 
catalytic site is totally buried. Substrates can only enter its catalytic site when 
through an interfacial activation, the lid conformation is changed to an open 
form and the active site is exposed. 
The little similarity of SpL with CALA and CALB in structure demonstrates 
that SpL is a novel aminolyase with respect not only to substrate specificity, as 
discussed in Chapter 3, but also to structure. 
 







4.3.7 Rationalisation of amine substrates with structure of SpL 
A series of good amine substrates other than 3-amino-5-methylisoxazole 2g 
were rationalized with the structure of SpL by docking them into the active 
site of SpL. The docking models were acquired by using Autodock Vina 
version 1.0 and visualized by PYMOL.222 
  
Figure 4.17 a) Docking mode of 5-amino-1, 3-dimethylpyrazole 2f into the X-
ray structure of SpL. b) Docking mode of 2-(aminomethyl)benzimidazole 2h 
into the X-ray structure of SpL. 
 
As shown in Figure 4.17, docking of these good amine substrates into the 
structure of SpL gives docking modes which place the amino group in the 
appropriate positions for reacting with the acyl enzyme intermediate. For 5-
amino-1, 3-dimethylpyrazole 2f, the amino group can be oriented near the 
nucleophilic serine in a reactive binding pose without any constraints, similar 
to that of the 3-amino-5-methylisoxazole case. Docking of 2-
(aminomethyl)benzimidazole 2h is a special case. Due to the interference from 
the amino group on the imidazole ring, it can only be docked into the active 
site of SpL when constrained to an amino group hydrogen bonding with the 
nucleophilic serine. 
These docking modes perfectly explained why SpL worked well with these 





4.3.8 HSL-like lipases as a group of potentially useful biocatalysts for 
amide synthesis 
HSL-like lipases are a group of bacterial lipid splitting enzymes with 
significant amino acid sequence similarity to the mammalian hormone 
sensitive lipases (abbreviated as HSLs).223 In the lipase and esterase 
classification system proposed by Jean Louis Arpigny and Karl-Erich Jaeger 
in 1999, HSL-like lipases are classified as group IV lipases.224 An important 
feature of this family of lipases is a highly conserved sequence HGGG 
upstream of the catalytic triad and a conserved catalytic serine residue sitting 





Figure 4.18 Multiple sequence alignment of HSL-like lipases and 
carboxylesterases from Sphingomonas sp. HXN-200 (SpL), Sulfolobus 
tokodaii (Sto-Est), Sulfolobus shibatae (Ssh), Archaeoglobus fulgidus (Afu), 
Bacillus megaterium (Bme) and Oleomonas sagaranensis (Osa). The signature 
HSL-like sequence is shown in square brackets. Amino acid residues forming 
the catalytic triad and oxyanion hole are indicated by open circles and open 
diamonds, respectively. 
 
Thermostable carboxylesterase from the thermoacidophilic archaeon 
Sulfolobus tokodaii (Sto-Est, 3AIO.pdb) is a HSL-like esterase with 
significant structure similarity to SpL.217 We were interested whether Sto-Est, 
like SpL, is also an efficient biocatalyst for amide synthesis. A series of ester 
aminolysis reactions were tested by using Sto-Est as the catalyst. Interestingly, 
Sto-Est is also a superior aminolyase for synthesis of a series of 
pharmaceutically valuable amides. 
As shown in Table 4.2, Sto-Est shows high activities for a series of 
heterocyclic aromatic amines and secondary amines investigated. It is 
interesting to note that compared with SpL, these activities are even higher, 
not to mention that the amide yields are also improved significantly. 
Table 4.2 Enzymatic synthesis of heterocyclic amides via aminolysis of ester 
1e with amines 2e-2i and 2l by free Sto-Est a  
 
Entry Ester Amine Amide Activity (U/g enzyme) b Yield (%) c 
1 1e 2e 3h 70.7 49.4 
2 1e 2f 3i 9.1 12.1 
3 1e 2g 3j 32.3 6.2 
4 1e 2h 3k 25.5 54.0 
5 1e 2i 3p 24.6 20.5 
6 1e 2l 3t 32.0 59.8 
 
a The reaction was performed with 10 mM of ester and 20 mM of amine in 5 
ml n-hexane with 1 mg of free Sto-Est at 30 oC. 4% (v/v) of water was added 
as activator. b Specific activity (U/g enzyme) was determined after 30 min. c 
Yield (%) to the amide was determined after 20 h. 
 
Sto-Est’s capability for amide synthesis is exiting since other HSL-like lipases 




Archaeoglobus fulgidus esterase (AFEST) and Alicyclobacillus 
acidocaldaricus esterase (PDB accession number: 2YH2.pdb, 1JJI.pdb and 
1EVQ.pdb) can also probably act as highly efficient aminolyases.134, 225, 226 In 
other words, the HSL-like lipase family is probably a group of novel enzymes 
which are potentially useful for amide synthesis in the pharmaceutical industry. 
It is worthwhile to note that HSL-like lipases are extensively present in almost 
all microorganisms due to its indispensible roles in cellular lipid metabolism 
and stored energy mobilization.223 Based on this knowledge, numerous whole 
genome data available in the NCBI database can be valuable resources for 
genome mining of highly efficient aminolyases by using the known HSL-like 
aminolyases such as SpL and Sto-Est as tempelates for high-throughput blast 
searching. Aminolyases with special properties such as high thermostability 
(thermophiles), high organic solvent tolerance (halophiles) or high activity at 
low temeperatures (psycrhophile) can also be specifically mined out by 
searching a series of extremephiles’ whole genome data, which we predict, 
will excel SpL, especially when applied in the real pharmaceutical 
manufacturing conditions. 
4.4 Conclusions 
SpL was purified to apparent homology by a two-step FPLC and crystallized 
in classics screening. Its X-ray structure was solved by molecular replacement 
of Sto-Est (a HSL-like carboxylesterase from a thermophilic anchea 
Sulfolobus tokodaii) to a resolution of 1.7 Å. The overall structure of SpL is 
quite similar to that of Sto-Est, containing a tunnel with two entrances as the 
active site. The catalytic triad (S159, D251 and H281) was found at the bottom 




3-amino-5-methylisoxazole were also obtained, respectively, which indicate 
access of an ester substrate through entrance 1 and of the amine substrate 
through entrance 2, respectively. Compared with other known aminolysis 
enzymes such as CALB having a catalytic pocket with one entrance, the HSL-
like lipase SpL has two different entrances, which can have better orientation 
and less confliction of ester and amine substrates inside the binding pocket 
thus can accept both bulky ester and bulky amine substrates simultaneously, 
giving rise to a broader substrate range for aminolysis. The thermostable HSL-
like carboxylesterase Sto-Est was cloned, expressed and produced in E. coli. 
Sto-Est was found to catalyze also the aminolyisis between a series of bulky 
esters and amines, with similar high activities as SpL. The discovery of 
bacterial HSL-like group of esterase for aminolysis of esters provides a new 
source of aminolysis enzymes for green and efficient synthesis of amides and 













Chapter 5. Protein engineering of SpL to broaden the 
substrate acceptance 
5.1 Introduction 
The activity of the currently used lipases for acylating secondary amines is 
normally low.18, 33 Candida antarctica lipase A (CALA) is the only enzyme 
known so far showing certain catalytic ability for secondary amines.86, 87 
However, highly active esters have to be used as acyl donors and this strongly 
limits its pharmaceutical application.86, 87  
SpL is an enzyme showing certain ability for acylating secondary amines, as 
shown in Chapter 3. However, the activity is still unsatisfactory and most 
importantly, there is still no activity detected for acylating highly bulky 
secondary amines, like those containing a boc group. 
Thanks to the rapid development of molecular biology, protein engineering 
emerged as a powerful tool to increase an enzyme’s acceptance for bulky 
substrates.41, 154 By creating mutations in the polypeptide chain, the protein’s 
structure is expected to be changed, and so does its catalytic properties. 
Fortunately, the structure of SpL complexed with 3-amino-5-methylisoxazole 
2g offers crucial information about how the amine substrate interacts with the 
protein structure during the reaction. 
We are quite interested to study whether by engineering a larger amine 
binding pocket based on the hot spots provided by the SpL-amine complex, 
the substrate scope of SpL could be expanded with improved activities for 





5.2 Experimental section 
5.2.1 Strains, plasmids and chemicals 
All the chemicals were obtained from commercial suppliers and used without 
further purification: 1-boc-piperazine 2l (97%, Sigma Aldrich), sodium 
bicarbonate (99%, Sigma Aldrich), sodium sulfate (≥99.0%, Sigma Aldrich), 
n-hexane (HPLC grade, TEDIA), chloroform (HPLC grade, Fisher), methanol 
(99.8%, Sigma Aldrich), acetonitrile (HPLC grade, TEDIA), dichloromethane 
(≥99.8%, Sigma Aldrich), EDCI (≥99.0%, Sigma Aldrich), HOBT (≥99.0%, 
Fluka), triethylamine (≥99%, Sigma Aldrich), 1-phenylethanol (98%, Sigma 
Aldrich), trifluoroacetic acid (99%, Sigma Aldrich) and molsieve 4A (powder, 
325 mesh, Sigma Aldrich).  
Escherichia coli T7 expression strain, restriction enzyme (DpnI), T4 
oligonucleotide kinase and T4 DNA quick ligase were purchased from New 
England Biolabs. Oligos (primers), IPTG (inducer, >99%), Agarose 
(molecular biology grade) and 10×TAE buffer (ultrapure grade) were 
purchased from 1st BASE, Singapore. Monopotassium phosphate (≥99.0%), 
dipotassium phosphate (≥98%), sodium phosphate dibasic heptahydrate 
(≥99.99%), sodium phosphate monobasic monohydrate (≥98%), sodium 
chloride (≥99.5%), calcium chloride dihydrate (≥99.0%), imidazole (≥99%), 
kanamycin (>99%), glycerol (≥99%) and Bradford reagent were purchased 
from Sigma Aldrich. Phusion DNA polymerase, plasmid miniprep kit and gel 
extraction kit were purchased from Thermo Scientific. LB broth, LB agar, 
tryptone and yeast extract were purchased from Biomed Diagnostics. 4%–12% 




from life technologies. Novozyme 435 is a gift from Novozymes (Bagsvaerd, 
Denmark). DNA sequencing was carried out by 1st BASE, Singapore. 
5.2.2 Directed site mutagenesis 
Site mutagenesis was done according to the standard procedure provided by 
New England Biolabs (Q5 site directed mutagenesis kit). The mutagenesis 
primers were designed with the mutation site be put on the 5’ end of the 
forward primer. The reverse primer was designed back to back to the forward 
primer. 
pRSFDuet-SpL (his-tagged) was used as the template for PCR and the 
following PCR program was used for the exponential amplification of the 
mutated plasmid: initial denaturation at 98 °C for 30 s, denaturation at 98 °C 
for 10 s, annealing at 72 °C for 30 s, extension at 72 °C for 3 min, total 33 
cycles, final extension at 72 °C for 10 min. 
The mutated plasmid acquired was then subjected to DpnI digestion to remove 
methylated template DNA and purified on 1% agarose gel in TAE buffer. The 
linear plasmid was then phosphorylated by T4 oligonucleotide kinase followed 
by a self-ligation with T4 DNA quick ligase to produce the circulated plasmid. 
The circulated plasmid was then used to transform Escherichia coli T7 express 
competent cells and positive transformants were selected on LB agar plates 
with 50 μg/ml of kanamycin present. The site mutagenesis was confirmed by 
DNA sequencing. 
A total number of 5 key amino acid residues were selected for site 
mutagenesis. Since A190 is the amino acid residue sitting most closely to the 
catalytic serine, in the first round, only this amino acid was selected and 




A190G was used as the template and all the other 4 amino acid residues were 
mutated to all the smaller hydrophobic amino acid residues (as shown in 
Table 5.1) and the activities towards aminolysis of methyl 1H-pyrazole-3-
carboxylate 1e with 1-boc-piperazine 2l were tested. 
Table 5.1 Primers used for site mutagenesis (the mutagenesis sites are marked 

























































5.2.3 Cell growth and protein expression 
E. coli (his-tagged SpL) or its mutants was firstly grown in LB medium (2 ml) 
containing kanamycin (50 μg/ml) at 37 °C for 4-6 h and then inoculated into 
TB (Terrific Broth) medium (50 ml) containing kanamycin (50 μg/ml). When 
OD600 reached 0.6-0.8 (around 110 min), IPTG (0.25 mM) was added to 
induce gene expression. The cells were let to continue growing for 14−16 h at 
22 °C and the cell density reached 6.4-7.2 g cdw/L. The cells were then 
harvested by centrifugation (5000 g, 5 min), washed with deionized water 
once and lyophilized for at least 24 h before subjected to activity test. 
5.2.4 Screening of engineered SpL mutants towards 1-boc-piperazine 
acylation activity 
E.coli (his-tagged SpL) was set as the control. 30 mg dry cell powder of E.coli 
(his-tagged SpL) or its mutants was added to a 2 ml safe-lock tube. 1 ml n-
hexane, 160 ul deionized water and 70 mM of 1-boc-piperazine 2l were then 
added and the mixture was shaken on a mixing block at 30 oC, 1000 rpm for 5 
min. 50 mM methyl 1H-pyrazole-3-carboxylate 1e was then added and the 
reaction was performed by shaking the mixture at 30 oC, 1000 rpm for 24 h. 
After reaction, n-hexane was removed by evaporating in a vacuum oven and 1 
ml acetonitrile was added to dissolve any possibly insoluable amide. 
Analytical samples were prepared by centrifugation and the supernatant was 
taken directly for MS analysis on an Agilent 6200 series Accurate-Mass Time 
of Flight (TOF) mass spectrometry without further handling. 
Samples showing a MS signal for 1-(1H-pyrazol-3-ylcarbonyl)-4-(tert-
butoxycarbonyl)piperazine 3t were further analyzed by a reverse phase HPLC 




using a mobile phase consisting of 25% acetonitrile and 75% water with 0.1% 
trifluoroacetic acid present at a flow rate of 0.8 ml/min. The retention time for 
3t is 5.5 min. 
5.2.5 Purification of his-tagged SpL (A190G) 
The expression of his-tagged SpL (A190G) was conducted in TB medium as 
described previously. After overnight protein expression, cells were harvested 
by centrifugation, washed with DI water once and then resuspended in KP 
buffer (10 mM, pH 8.0). The cell suspension was then let pass through a 
homogenizer twice, followed by centrifugation (23000 g, 4 oC for 50 min) to 
remove the cell debris. The cell free extract was filtered with sterile Acrodisc® 
syringe filters with 0.2 μm Supor® membrane to remove small particles 
present and then subjected to affinity chromatography for protein purification. 
The purification was performed on an AKTA purifier equipped with a Ni-
NTA column. The cell free extract was loaded onto the Ni-NTA column 
manually. Impure proteins were then washed out by using a wash buffer (20 
mM sodium phosphate, 500 mM NaCl, 30 mM imidazole, pH 7.4). After the 
280 nm absorption value indicated that all the impurities have been removed, a 
wash buffer (20 mM sodium phosphate, 500 mM NaCl, 300 mM imidazole, 
pH 7.4) was used to wash out the target protein. The salts and imidazole 
present in the enzyme solution were removed by washing the protein solution 
with deionized water in an Amicon Ultra-15 Centrifugal Filter Units (20 kD). 
The protein solution was then lyophilized for at least 24 h to acquire the dry 
enzyme powder for further activity test. 
5.2.6 Activity test for SpL, SpL (A190G) and Novozyme 435 




shaking flask. 5 ml of n-hexane, 200 ul of deionized water (for SpL and SpL 
(A190G)), 200 mg activated 4A molecular sieve powder (for Novozyme 435), 
20 mM of 1-boc-piperazine 2l were then added and the reaction mixture was 
equilibrated by shaking in an incubator at 30 °C, 250 rpm for 5 min. Then 10 
mM of methyl 1H-pyrazole-3-carboxylate 1e was added and the reaction was 
performed by shaking the reaction mixture in an incubator at 30 °C, 250 rpm 
for 30 min (for measuring the initial reaction rate or final amide yield) and 20 
h (for measuring the final amide yield). 
After reaction, n-hexane was removed by evaporating in a rotary evaporator 
and 5 ml methanol was added to dissolve any possibly insoluble amide. 1 ml 
aliquot was removed for HPLC analysis. Analytic samples were prepared by 
centrifugation, and then 200 ul of supernatant were mixed with 200 ul 
methanol (2 mM 1-phenylethanol as internal standard) before HPLC analysis 
for quantification of the concentration of the amide. 
5.2.7 Crystallization and structure determination of SpL (A190G) 
SpL (A190G) was purified to apparent homology and concentrated to 68 
mg/ml for crystallization screening experiments. The initial screening was 
performed with three sparse matrix (Classics, Pegs I and Pegs II) and high 
quality crystals were obtained from Classics screening. The good conditions 
for crystallizing SpL (A190G) is 0.1 M sodium cacodylate buffer at pH 6.5 
with 30% PEG 8000 as the precipitant and 0.2 M sodium acetate as the salt, 
same as the good condition for crystallizing SpL. The structure of SpL 
(A190G) was solved by molecular replacement using the coordinates of SpL 





5.3 Results and discussion 
5.3.1 Hot spots provided by the SpL-amine complex for engineering of the 
amine specificity of SpL 
The binding pocket of SpL for amine is quite hydrophobic, as shown in 
Figure 5.1. Through an amino group hydrogen bonding with the active site 
serine and a series of hydrophobic interactions between the isoxazole ring and 
the surrounding hydrophobic amino acid residues (A190, L209, L253, M214, 
F217 and W94), 3-amino-5-methylisoxazole 2g is fixed at a reactive pose, at 
which its amino group is located 2.9 Å from the nucleophilic serine, within a 
distance range for reaction. On one hand, L209, L253 and W94 help prevent 
the isoxazole ring from moving out of its plane. On the other hand, A190 and 
F217 fix the isoxazole ring to prevent it from moving in its plane. 
M214, A190, F217, W94, L209 and L253 are amino acid residues located 
close to 3-amino-5-methylisoxazole in the SpL-amine complex. Based on the 
theory that structure determines function, specificity of SpL towards amine is 
highly likely to be altered by changing the size or nature of these amino acid 
residues. More specifically, engineering a larger amine binding pocket by 
substituting the bulky amino acid residues with small ones might endow SpL 







Figure 5.1 Amine binding site of SpL. The amino acid residues surrounding 
the 3-amino-5-methylisoxazole molecule 2g are highlighted. 
 
Since M214 is the “goalkeeper” which guards the entrance to the amine 
binding pocket, it was not subjected to site mutagenesis. Except for it, all the 
other 5 amino acid residues were screened for the effect on SpL’s acceptance 
for 1-boc-piperazine 2l. 
As shown in Figure 5.2 and 5.3, a double mutation of A190G and F217A will 
create more room in the plane of isoxazole and another double mutation of 













Figure 5.2 Molecular modelling of the amine binding pocket change of SpL 
by a double mutation of A190G and F217A. PS: more room will be created in 
the plane of isoxazole by making these two site mutagenesis. 
 
 
Figure 5.3 Molecular modelling of the amine binding pocket change of SpL 
by a double mutation of W94F and L253A. PS: more room will be created out 












5.3.2 Screening of engineered SpL mutants towards 1-boc-piperazine 
acylation activity 
Since A190 is the amino acid residue sitting most close to the catalytic serine, 
a single mutant of SpL (A190G) was firstly engineered to test the activity for 
aminolysis of methyl 1H-pyrazole-3-carboxylate 1e with 1-boc-piperazine 2l. 
A high specific activity of 101.6 U/g was detected for the single mutant of 
SpL (A190G) for acylation of 1-boc-piperazine 2l. It is worthwhile to note that 
Novozyme 435, by far the most widely used enzyme for aminolysis of esters, 
shows almost no activity for acylating 1-boc-piperazine 2l. 
 
 
Figure 5.4 a) Reverse phase HPLC chromatogram on BC-Poroshell 120 SB-
Aq column (100 × 4.6 mm, 2.7 μm) of 3t prepared by EDCI and HOBT 
mediated coupling of 4b and 2l and purified by washing with water; b) 
Reverse phase HPLC chromatogram on BC-Poroshell 120 SB-Aq column 
(100 × 4.6 mm, 2.7 μm) of the reaction mixture of SpL (A190G) catalyzed 













Figure 5.5 Mass spectroscopy of the reaction mixture of SpL (A190G) 
catalyzed aminolysis of 1e with 2l at 30 min 
 
The tremendous improvement of catalytic performance of SpL for acylating 1-
boc-piperazine 2l by a single mutation of A190G is possibly due to the methyl 
group deletion near the nucleophilic serine just right leaves enough space to 
accommodate the bulky secondary amine moiety in 1-boc-piperazine 2l. This 
is supported by the fact that SpL shows a high specific activity for acylating 
cyclohexylamine (data not shown), which is very similar to piperazine 
structurally. It is interesting to note that the amine group in cyclohexylamine is 
1 methyl group farther away from the ring compared with 1-boc-piperazine. 
This is just the distance which is created by a single mutation of A190G. 
Scheme 5.1 Aminolysis of methyl 1H-pyrazole-3-carboxylate 1e with 1-






















Further mutation of the other 4 amino acid residues based on A190G has a 
negative effect on the catalytic activity. As shown in Table 5.3, an A190G 





piperazine 2l. Tryptophan and phenylalanine are both non-polar amino acids, 
but phenylalanine has a much smaller side chain group. The W to F mutation 
might allow the free rotation of the piperazine ring in the binding pocket and 
thus results in disorientation of the substrate. The essential role of W94 in 
maintaining the structure integrity of SpL is further supported by the multiple 
sequence alignment result, as shown in Figure 4.18. The first amino acid 
residue after the conserved sequence HGGG is always a W or F in all of the 
HSL-like lipases. Considering the fact that the last two glycines in HGGG 
constitute the oxyanion hole, a bulky W94 following might be essential in 
keeping its stability and is thus essential for keeping the catalytic activity. 
Table 5.2 Aminolysis of methyl 1H-pyrazole-3-carboxylate 1e with 1-boc-
piperazine 2l catalyzed by free SpL, free SpL (A190G) or Novozyme 435 a 
Entry Enzyme Time (h) Activity (U/g enzyme) b Yield (%) c 
1 SpL 20 0 0 
2 SpL (A190G) 0.5 101.6 61.0 
3 Nov 435 20 ~0 0.9 
 
a The reaction was performed with 10 mM of ester and 20 mM of amine in 5 
ml n-hexane with 10 mg of free SpL, free SpL (A190G) or Novozyme 435 as 
catalyst at 30 oC. For SpL and SpL (A190G), 4% of water (v/v) was added as 
activator. For Novozyme 435, 200 mg of activated molsieve 4A was added to 
keep absolute water free conditions. b Specific activity (U/g enzyme) was 
determined after 30 min. c Yield (%) to the amide was determined after the 
time stated in the table. 
 
Change of F217, L253 and L209 to smaller amino acid residues also leads to a 
decrease trend of catalytic activity, with the catalytic activity be lower when 
the substituted amino acid residue be smaller. This demonstrates that these 
amino acid residues are also important for the fixation of the substrate in a 





Table 5.3 Relative activities of SpL, SpL (A190G) and a series of SpL double 
mutants for acylation of 1-boc-piperazine 2l with methyl 1H-pyrazole-3-
carboxylate 1e a 
 
SpL or its mutant Relative activity b 
SpL  0 
A190G 1 
A190G L253G 0.09 
A190G L253A 0.23 
A190G L253V 0.95 
A190G L253I 0.93 
A190G L209G 0.03 
A190G L209A 0.35 
A190G L209V 0.78 
A190G L209I 0.94 
A190G F217G 0 
A190G F217A 0 
A190G F217V 0 
A190G F217I 0.63 
A190G F217L 0.80 
A190G F217M 0.65 
A190G W94F 0 
 
a The reaction was performed with 50 mM methyl 1H-pyrazole-3-carboxylate 
1e and 70 mM 1-boc-piperazine 2l in 1 ml n-hexane with 30 mg lyophilized 
cell powder of E. coli (SpL or its variant) as the catalyst. 160 ul of water was 
added as the activator. b Specific activity (U/g cdw) was determined after 20 h. 
 
5.3.3 Crystallization and structure determination of SpL (A190G) 
SpL (A190G) was crystallized in the same condition as crystallizng SpL. Its 
X-ray structure was solved to a 1.6 Å resolution by molecular replacement of 
SpL. 
The A190G structure is essentially identical to that of the wild-type enzyme 
and the A190G mutation is clearly visible in the data. A larger space roughly 
the methyl group size near the nucleophilic serine was created by this single 
site mutation, similar as the modelling result as shown in Figure 5.2. Now we 




clarify the detailed mechanism of the tremendous improvement of the catalytic 
activity in the A190G mutant. 
 
Figure 5.6 Crystals of his-tagged SpL (A190G) 
5.4 Conclusions 
SpL is an enzyme showing certain catalytic activity for acylating secondary 
amines. However, it still shows low activities for acylating highly bulky 
secondary amines like 1-boc-piperazine. To improve SpL’s catalytic 
performance for acylating 1-boc-piperazine, 5 hot spots (A190, L209, L253, 
F217 and W94) were identified from the SpL-3-amino-5-methylisoxazole 
complex for engineering the amine specificity of SpL. A single mutant 
(A190G) was found to be highly active for acylating 1-boc-piperazine with 
methyl 1H-pyrazole-3-carboxylate. Larger space adjacent to the active site 
serine was found in the A190G mutant, which could accommodate the bulky 
secondary amine moiety in 1-boc-piperazine. This is the first example of 
protein engineering of an aminolysis enzyme with expanded substrate scope 
for better acceptance for secondary amines. Further mutation of the other 4 
amino acid residues (W94, F217, L209 and L253) leads to a decrease trend of 
catalytic activity, with the catalytic activity be lower when the substituted 




residues are essential for orientation of the substratre at a reactive binding pose 
in the substrate binding pocket. Cocrystallization of SpL (A190G) with 1-boc-
piperazine 2l to clarify the detailed mechanism of the tremendous 

























Chapter 6. Conclusion and recommendations 
6.1 Conclusion 
Amide bonds are indispensable functioning groups in the pharmaceutical 
industry. However, acid chlorides and coupling reagents are normally 
associated with the amide bond formation reactions, which suffer several 
drawbacks from a green chemistry perspective of view such as the 
involvement of corrosive reactants and products, the use of shock sensitive 
reagents and poor atom economy.  
Enzyme-catalyzed aminolysis of ester offers an alternative for green and direct 
synthesis of amides. Compared with the traditional chemical approaches, it has 
several advantages such as mild reaction conditions, no shock sensitive 
reagents included, high atom economy and most importantly, inherent high 
chemo-, regio- and enantio-selectivity. However, there are still several major 
challenges such as the limited scope of enzymes which can be used in the 
industry and the restricted substrate scope of the now existing enzymes 
associated with the enzyme mediated amide formation. 
In this thesis, we 1) discovered a novel HSL-like lipase SpL as an efficient 
biocatalyst for synthesis of a series of pharmaceutically important amides with 
high activity and enantioselectivity; 2) solved SpL’s crystal structure and 
proved that the HSL-like lipases are a group of enzymes with novel 
application for amide synthesis in the pharmaceutical manufacturing; 3) 
acquired SpL’s structure complexed with an arsenic inhibitor and an amine 
substrate to elucidate the catalytic mechanism of SpL-catalyzed aminolysis of 





Sphingomonas sp. HXN-200, Rhodococcus sp. MHD 246, Rhodococcus sp. 
MHD 280 and Bacillus sp. ATOL-1 were identified as highly active whole 
cell biocatalysts for aminolysis of esters by strain screening. A unique 
intracellular HSL-like lipase (SpL) from Sphingomonas sp. HXN-200 was 
cloned as a highly active and enantioselective enzyme for aminolysis of esters. 
This enzyme was found to be quite different from the well-known enzymes for 
aminolysis such as Candida antarctica lipase B (CALB), in that it is an 
intracellular enzyme and shows good catalytic activity in the presence of water. 
Surprisingly, SpL is a highly active enzyme for accepting carboxylic acids as 
the aminolysis substrates, which is generally considered infeasible using the 
currently available enzyme collections. 
SpL has a broad scope of substrates, with uniquely good acceptance for a 
series of chemically inert aromatic amines and bulky secondary amines, for 
which CALB gave no or nearly no activities. In addition to the high activity, 
SpL demonstrated also much better enantioselectivities for several target 
aminolysis reactions than CALB. A recombinant Escherichia coli expressing 
SpL [E. coli (SpL)] was engineered as an efficient and also the first whole-cell 
based aminolysis catalyst. Amides were synthesized in high concentration (up 
to 103 mM) in high yield and short reaction time with the easily available and 
low-cost wet cells of E. coli (SpL). 
To study the structural and functional relationship, SpL was purified to 
apparent homology and crystallized. Its X-ray structure was solved by 
molecular replacement of Sto-Est (a HSL-like carboxylesterase from a 
thermophilic anchea Sulfolobus tokodaii) to a resolution of 1.7 Å. The overall 




two entrances as the active site. The catalytic triad (S159, D251 and H281) 
was found at the bottom of the tunnel. The crystal structures of SpL with 
dimethylarsinic acid and with 3-amino-5-methylisoxazole were also obtained, 
respectively, which indicate the accessing of an ester substrate from entrance 1 
and an amine substrate from entrance 2, respectively. Compared with other 
known aminolysis enzymes such as CALB having a catalytic pocket with one 
entrance, the HSL-like lipase SpL have two different entrances, which can 
accept both bulky ester and bulky amine substrates simultaneously, giving rise 
to a broader substrate range for aminolysis. The thermostable HSL-like 
carboxylesterase Sto-Est was cloned, expressed and produced in E. coli. Sto-
Est was found to catalyze also the aminolysis between a series of bulky esters 
and amines, with similar high activities as SpL. The discovery of bacterial 
HSL-like group of esterase for aminolysis of esters provides with new source 
of aminolysis enzymes for green and efficient synthesis of amides and 
significantly expands the application scope of enzymatic aminolysis for amide 
synthesis. 
Considering the restricted activity of the wild-type SpL for acylating highly 
bulky secondary amines like 1-boc-piperazine, 5 key amino acid residues 
(W94, A190, L209, F217 and L253) around 3-amino-5-methylisoxazole in 
SpL were chosen and subjected to site mutagenesis. A single mutant A190G 
of SpL was found to be highly active for acylating of 1-boc-piperazine with 
methyl 1H-pyrazole-3-carboxylate, improving the activity from 0 to a 
noticeable activity of 101.6 U/g enzyme. This is the first example of 






First of all, since the details about how the ester and amine substrates interact 
with SpL are known, site saturation mutagenesis can be used for improving 
SpL’s performance for heterocyclic aromatic amines or secondary amines 
further. This systematic way of protein engineering, we believe, will give a 
more comprehensive coverage of the positive mutations and provide better 
results as compared with the site mutagenesis guided by rational design. 
Secondly, since SpL needs to be used in partially hydrated organic solvent, the 
parallel hydrolysis reaction is bound to happen and this will cause some acyl 
donor loss. Protein engineering towards increasing the water tolerance of SpL 
(SpL can be used in total aqueous buffer without much acyl donor hydrolysis) 
or decreasing SpL’s water tolerance (SpL can be used in totally anhydrous 
organic solvent with significant activity) is worth investigating since 
increasing the water tolerance of SpL will exempt the use of organic solvent, 
which will make the process become greener and the use of totally anhydrous 
organic solvent, on the other hand, will give quantative amide yield 
theoterically. 
Thirdly, SpL can be immobilized for acquiring highly active biocatalyst with 
good recyclability to reduce the cost further. A series of commercially 
available resins such as Lewatit E could be used as cheap and easily available 
materials for immobilization of SpL. To achieve higher specific activities and 
better mass transfer rate, a series of nano supports such as Ni-NTA 
functionalized nanoparticles could be utilized for fast purification and 
immobilization of SpL in one pot, which we believe, would be better than 




Last but not least, genome mining of a series of extremephiles’ whole 
genomes will probably give aminolyases with special properties such as high 
thermostability (thermophiles), high organic solvent tolerance (halophiles) or 
high activity at low temeperatures (psycrhophiles), which are potentially 
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